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ABSTRACT

PROTEIN AND ENDOTOXIN INTERACTIONS
AND ENDOTOXIN REMOVAL FROM PROTEIN SOLUTIONS

by
Liping Li

The investigation objectives of this study include: endotoxin disaggregation by proteins;
protein concentration effect on protein-endotoxin binding and endotoxin removal; size
exclusion high performance liquid chromatography (SE-HPLC) studies on endotoxin
dissociation by bovin serum albumin (BSA); use of Ca+2 to re-aggregate endotoxin in
hemoglobin solutions and the subsequent removal of endotoxin by ultrafiltration;
quantitative determination of Ca +2 effects on endotoxin removal and protein yield in a
two-stage ultrafiltration.
It is known that some proteins can disaggregate endotoxins and form complexes
with lipopolysaccharides (LPS). It is also known that Ca +2 can act as "bridges" to
aggregate LPS in aqueous solutions. However many questions remain unanswered. What
are the effects of protein concentration on such LPS disaggregation? Can Ca +2 act as
"bridges" to re-aggregate LPS subunits in protein solution where LPS vesicles have been
disaggregated by protein molecules into small fragments? How will the presence of Ca +2
affect the endotoxin removal and protein recovery? This study will investigate these
problems.
The effects of protein concentration on endotoxin disaggregation, protein-LPS
binding, and endotoxin removal have been investigated. It was found that hemoglobin A,

and albumin could disaggregate LPS and their concentrations had significant effects on
protein-LPS interaction. In contrast, lysozyme and cytochrome C did not disaggregate
LPS.
In the study of size exclusion high performance liquid chromatography (SEHPLC) studies on endotoxin dissociation by bovine serum albumin (BSA), it was found
that BSA could disaggregate LPS. BSA concentration had a significant effect on the LPS
disaggregation. Pre-incubation of the BSA-LPS mixture could enhance the LPS
disaggregation.
Ca+2 was used to re-aggregate endotoxin in hemoglobin solutions and to
subsequently remove endotoxin by ultrafiltration. It was found that Ca +2 could reaggregate LPS in protein solutions where LPS had been disaggregated by hemoglobin A 0 .
Such re-aggregation improved the endotoxin removal efficiency by ultrafiltration.
In the study of quantitative determination of Ca+2 effects on endotoxin removal
and protein yield in a two-stage ultrafiltration, it was found Ca +2 would re-aggregate LPS
from protein solution. In the presence of Ca +2 , endotoxin removal efficiency was
increased without sacrificing the protein yield.
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CHAPTER 1

INTRODUCTION

1.1 Endotoxin and Pyrogenic Reactions
Bacterial endotoxins are lipopolysaccharide (LPS) derived from the outer cell membranes
of Gram-negative bacteria (Hou and Zaniewski, 1990). Endotoxins are known to have
potent biological effects in man and in many animal species when administered
systemically (Issekutz, 1983). Endotoxins are pyrogenic; that is, they produce fever in
man or other mammals. Even if the bacteria are killed, endotoxin removal is essential for
the safe parenteral administration of products produced from natural sources or by
recombinant DNA technology. The sensitivity of mammals to LPS pyrogens is
extraordinary. Contamination levels of less than 1 ng/ml elicit a strong fever response and
can even result in death (Nelsen, 1978).
The property of the LPS pyrogen explains why elimination of pyrogens from
aqueous solution is problematic. The molecule is unusually thermally stable, although
exposure to dry heat at 250 ° C for periods up to an hour will destroy it. The molecule is
relatively insensitive to changes in pH as well, although high concentrations of acids and
bases (usually at levels that would also destroy the desired material containing pyrogen)
may deactive the molecule (Nelsen, 1978).
The LPS molecule is anionic or negatively charged because of its phospholipid
group. It may, therefore, be eliminated at least in theory, by binding on positively charged
adsorbents (Nolazn et al., 1975).
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In practice, however, this binding is relatively inefficient, presumably because of
its relatively low charge density and because of its unusual molecular weight
characteristics. Pyrogen range in size from subunits of 10, 000-20, 000 to aggregates of
0.1 µm in diameter (Hannecart-Pokorni et al., 1973). In aqueous solutions, the
hydrophobic regions of LPS molecules tend to associate and form large aggregates; the
unaggregated LPS subunit is seldom found. The degree of aggregation can be either
enhanced or inhibited by the presence or absence of protein due to protein and endotoxin
interaction, divalent cations, chelating agents, and detergents (Nelsen, 1978; Sweadner et
al., 1977).
Divalent cations, such as Ca2+ or Mg 2+ , cause LPS molecules to aggregate into
large vesicles. In the absence of these ions, the vesicles dissociate into micelles of
300,000-l,000,000 molecular weight. (Sweadner et al., 1977).
The presence of chelating agents, such as EDTA, bind up the divalent ions in
solution and cause the subsequent disaggregation of vesicles into micelles. (Nelsen, 1978;
Rogers et al., 1969). The presence of strong detergents or bile salts also cause the
disaggregation of vesicles and/or micelles into basic LPS subunits (10,000-20,000 Da)
(Nelsen, 1978; Oroszian et al., 1963).
In the presence of some proteins, such as hemoglobin and serum albumin,
endotoxin aggregate states also change and form complexes with proteins. This has been
proved by sucrose density gradient, ultrafiltration, and chromatography method (Roth et
al., 1994; David et al., 1995).
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These facts make decontamination or removal of endotoxins from solutions a
problem in biological research as well as in the commercial production of
biopharmaceuticals by recombinant DNA technology.

1.2 Endotoxin and Biotechnology
Bacterial endotoxins are lipopolysaccharides (LPS) derived from the outer membranes of
gram negative bacteria (Pearson, 1985a). Endotoxin contamination during manufacture of
water for injection (WFI) and parenteral solutions is of great concern to the
pharmaceutical industry. Endotoxins are responsible for most pyrogenic reactions if they
occur in sufficient amounts in large volume parenterals (infusion fluids) (Baggerman et
al,, 1985; Evans-Strikfaden et al., 1996). Endotoxins in distilled water cause serious
complications as they can be present in kidney dialysis machines and intravenously
infused nutrients, pharmaceutical agents and various other products. Endotoxins were
also shown to cause disease in animals (Gerba and Goyal, 1981). The physiopathological
effects shown by affected humans or animals include pyrogenicity, endotoxemia,
leucopenia, leucocytosis, shock, allergic reactions and lowered blood pressure (Enterline
et al., 1985).
Gram-negative bacteria are widely used in biotechnology industry to produce
recombinant DNA products such as peptides and proteins. Bacterial endotoxins have
been recognized by the industry as a major cause of the pyrogenic reactions that can be
encountered during the administration of biotherapeutics. The removal of these
physiologically active agents from final bioproducts has always been a challenge.
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Because proteins are biologically active and sensitive to pH or temperature changes,
endotoxin removal from protein solutions is more complicated than that from water.
The applications of genetic engineering fall into two broad categories: (a)
modification of the structure or amplification of the production of scarce biological
products by cloning the relevant genes in bacteria. This method use bacteria as factories
for the production of target compounds. (b) Alteration of selected organisms to improve
their utility in a desired environment, such as the development of a bacterium which
imparts novel texture or flavor when used in cheese production (Sharma, 1986).
There is growing interest in the production and isolation of enzymes and other
proteins from microorganisms. This has been stimulated by the increasing use of
enzymes as industrial catalyst or in clinical analysis and the potential applications of
pharmacologically active polypeptides resulting the advent of recombinant DNA
techniques.
Recombinant DNA technology used for the production of pharmaceutically useful
polypeptides such as insulin, human growth hormone (Goeddel et al., 1979), and
interferons (Nagata et al., 1980; Goeddel et al., 1980; Goeddel et al., 1981; Gray et al.,
1982) has been intimately linked to the E. coli expression system. The microbe was the
first prokaryote used for the commercial production of insulin via a cloned gene. The
gram-negative organism has been a favorite for at least three reasons. It has relatively
simple genetics, is well characterized, and has a rapid growth rate. However, E. coli as a
host for an eukaryotic gene encoding a useful polypeptide or protein has defects. One
defect which received early extensive notoriety is the production of an endotoxin by E.
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coli. Obviously, there are some inherent problems associated with this organism as it
relates to the purification of products produced by recombinant DNA technology.
Administrating human proteins derived by recombinant DNA technology has the
potential of unknown risks, concerned with the production of biopharmaceuticals derived
from E. coli. The questions that are relevant are: what are the clinical implications? How
serious are such problems? Bacterial contaminants, even at a relatively low
concentration, could give rise to undesirable side effects. As mentioned above
contamination levels of less than 1 ng/ml elicit a strong fever response and can even
result in death (Nelsen, 1978).
In the biotechnology industry, Gram-negative bacteria are widely used to produce
recombinant DNA products, such as peptides and proteins, bacterial endotoxins have
been recognized as a major cause of the pyrogenic reactions that can be encountered
during the administration of biological therapeutics. The removal of these physiologically
active agents from final bioproducts has always been a challenge to the industry. Then
the final problem is: how to remove the contaminants such as endotoxins.
To solve the problem it is essential to understand endotoxin characteristics in
biological solution. It is known that some proteins can disaggregate endotoxins and form
complexes with lipopolysaccharide in biological solutions, which makes the removal of
endotoxins from protein based biopharmaceutical products more complicated. Some of
such proteins have been identified, such as lipoproteins (Schlichting et al., 1996) and
monoclonal antibodies (Ziegler et al., 1991). It is reported that hemoglobin not only can
bind but also disaggregate endotoxins, and enhance endotoxin activation of Limulus
amebocyte lysate (LAL) in a concentration dependent manner (Kaca et al., 1994; Roth et

al., 1994). Variable effects of human serum albumin (HSA) on endotoxin biological
activity have also been reported. The biological activity of endotoxin is changed in the
presence of HSA, depending on HSA concentration (Kaca et al., 1994).

1.3 Research Objectives
1.3.1 Endotoxin Disaggregation by Protein and Protein Concentration Effect on
Protein-LPS Binding and Endotoxin Removal
To understand endotoxin characteristics in a biological solution, studies were carried out
using ultrafiltration membrane to investigate whether other proteins also have interactions
with endotoxin and disaggregate endotoxin. Several protein preparations (human
hemoglobin, bovine serum albumin, lysozyme, and cytochrom C) at different
concentrations were mixed with endotoxin from Escherichia coli 026:B6 respectively,
and then ultrafiltered using a 300,000 molecular weight cut—off polysulfone membrane.
Membrane filtrates were subjected to gelation Limulus amebocyte lysate (LAL) test. If
protein interacted with endotoxin and disaggregated endotoxin into smaller fragments,
the endotoxin content in the membrane filtrate would be detected by LAL test. The
results are shown in Chapter 3.
However, how the concentration of these proteins, which have interaction with
endotoxin and disaggregate endotoxin, affects protein-LPS binding and endotoxin
removal is unknown. The information will be very useful for design and improvement of
ultrafiltration membrane processes for removing endotoxin from protein solutions. In the
following study, an ultrafiltration method was used to investigate protein concentration
effect on protein-LPS binding and endotoxin removal. Protein samples at various
concentrations were incubated with endotoxin samples from Escherichia coli 026:B6 at a
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fixed concentration. After incubation, the mixtures were filtered with 300,000 nominal
molecular weight cut-off (NMWCO) polysulfone ultrafiltration membranes. Limulus
amebocyte lysate (LAL) test was employed to detect endotoxin in the filtrates. This is the
first time that the relationship between protein concentration and endotoxin
disaggregation is determined. The results are shown in Chapter 3.

1.3.2 Endotoxin Disaggregation by Bovine Serum Albumin
Although we already know that some proteins have interaction with endotoxin and
disaggregate endotoxin, the following questions are still unknown: what is endotoxin
disaggregation rate; whether endotoxin is partially or completely disaggregated; how
does the endotoxin form change before and after disaggregation, and what elements
affect such disaggregation. To further elucidate how protein disaggregates endotoxin, size
exclusion high performance liquid chromatography (SE-HPLC) was employed. This is
the first time size exclusion chromatography was combined with UV detection has been
used to study endotoxin disaggregation. The results are presented in Chapter 4.
Size exclusion high performance liquid chromatography (SE-HPLC) method was
used to investigate LPS disaggregation in the presence of bovine serum albumin (BSA).
Ultraviolet (UV) absorbance was employed as a detection method to obtain the
chromatography profile. This is the most elucidative way to demonstrate LPS
disaggregation. Protein and endotoxin mixture samples at various concentration ratios,
which were incubated at 37 ° C for 30 min or directly set at room temperature without
incubation, were analyzed by size exclusion high-performance chromatography (SEHPLC). Size exclusion chromatography separates molecules on the basis of molecular
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size, that is, molecules are eluted in order of decreasing molecular size. If endotoxin is
disaggregated by protein to form smaller size aggregates, such smaller size aggregates
will be eluted at longer retention time compared with the not-disaggregated endotoxin
aggregates. From the chromatograph profile, it can be seen see that the area of the first
LPS aggregate peak, which is produced by the larger aggregates, will decrease under the
effect of bovine serum albumin (BSA) and switch to longer retention time. Therefore the
area of LPS peaks, which are smaller than the first peak and eluted at longer retention
time, will increase. It was also found that at high BSA/LPS ratio under incubation
condition, the smallest size new peak groups were formed.

1.3.3 Use of Ca +2 to Re-Aggregate Endotoxin in Protein Solution and Subsequent
Removal of Endotoxin by Ultrafiltration
We already know that some proteins, such as hemoglobin and albumin, have interaction
with endotoxin and disaggregate endotoxin. This makes endotoxin removal in such
protein solution more complicated. Another problem is how to remove endotoxin in the
presence of protein. Here investigation was performed to find a way to re-aggregate
endotoxin in protein in order to remove it with ultrafiltration membrane. Some studies
have shown that the addition of divalent cations enhanced the LPS aggregation in water
(Galanos and Lüderitz, 1975). However, whether the LPS subunits bound to protein
molecules in a biological solution will re-aggregate by adding divalent cations is
unknown. Finding an answer to this problem will help to find an easy and non-toxic way
to remove endotoxin from biological solution. The following study was focused on this
problem. In that study, a method of two-stage ultrafiltration was used to investigate the
effect of Ca+2 on LPS re-aggregation in hemoglobin solutions and the removal of

9
endotoxin. Gelation Limulus amebocyte lysate (LAL) test was used to quantified the Ca +2
effect. Before this study, all other studies concentrated on Ca +2 influence on endotoxin
aggregate size in aqueous solution. This study found a new application of Ca +2 on
improving endotoxin removal in protein solution. The qualitative endotoxin removal
results are shown in Chapter 5.

1.3.4 Quantitative Determination of Ca +2 Effects on Endotoxin Removal and the
Subsequent Removal of Endotoxin by Ultrafiltration
From the above studies, the qualitative effect of Ca +2 on endotoxin removal would be
already known. To get quantitative Ca +2 effect on endotoxin removal and protein yield,
another experiment was carried out. Since the chromogenic LAL assay was employed to
detect endotoxin, it was possible to determine endotoxin concentration quantitatively.
The endotoxin removal efficiency after re-aggregation in the presence of Ca +2 was
studied. The yield of hemoglobin was also investigated. The results are shown in Chapter
6.

CHAPTER 2

LITERATURE REVIEW OF ENDOTOXIN, PROTEIN AND ENDOTOXIN
INTERACTION, ENDOTOXIN REMOVAL

2.1 Chemistry and Structure of Endotoxin
About 100 years ago (1892-95), Richard Pfeiffer investigated host-parasite
interrelationships, especially in Cholera infections. He showed that Vibrio cholerae
produce two quite different types of toxic principles, heat-labile endotoxin which is
released from living organisms during growth, and a heat-stable toxin which is released
only when the bacterial cells undergo disintegration, then called endotoxin (Rietschel,
1984). In the available literature there is no authentic paper in which Pfeiffer actually
introduces the term endotoxin. After 1904 many articles and reviews referred to Pfeiffer
(Wolff, 1904), but in none of the quoted articles is endotoxin really mentioned. In any
case, there is no doubt that it was Pfeiffer who first introduced the term endotoxin.
A bacterial or prokaryotic cell is surrounded by an envelope that maintains the
organism's shape and integrity. In gram-negative bacteria, this envelope consists of two
lipid layers. The inner layer is composed of phospholipids and proteins, and the outer
layer contains proteins and lipopolysaccharide (LPS), an endotoxin (Glauert and
Thornley, 1969). As is shown in Figure 2.1, lipopolysaccharide (LPS) or endotoxin is a
macromolecular substance tightly bound to the surface of gram-negative bacteria and
forming an integral part of the membrane structure (Galanos and Luderitz, 1984).
This outer layer reacts to changes in the environment. It inhibits the entrance of
toxic compounds, such as antibiotics (Rietschel et al., 1994) and is important in nutrient
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transport. This outer layer mediates the physiological and pathophysiological interaction
of the bacterium with the host organism. LPS is the main antigen of gram-negative
bacteria, carrying the antigenic determinants of 0 specificity (Westphal et al., 1983). It is
responsible for many pathophysiological activities that accompany gram-negative
infections (Luderitz et al., 1982). Furthermore, LPS is receptor for many bacteriophages
(Lindberg, 1973).
Chemically, LPS consists of two parts of contrasting chemical and physical
properties; a hydrophilic polysaccharide and a hydrophobic lipid, the lipid A (Figure 2.2).
The polysaccharide may be further subdivided into the 0-specific polysaccharide and the
core oligosaccharide. LPS shows considerable heterogeneity, even when isolated from a
single bacterial culture. This heterogeneity occurs because bacteria synthesize various
LPS molecules that differ in the length of the 0-specific chains (Rietschel et al., 1994).
The hydrophobic moiety of LPS, lipid A, is responsible for a great number of biological
processes observed in infections, inflammation, and some chromic diseases.
The 0-specific chain is a polymer of oligosaccharides with repeating units
consisting of 1 to 8 glycosyl residues. The structure of the repeating units differs among
bacterial strains (Malchesky et al., 1995). Compared with the 0-antigen, the core
oligosaccharide has a conserved structure with an inner KDO-heptose region and an outer
hexose region, In E. coli species, five different core types are known. Salmonella species
share only one core structure.
The most conservative part of endotoxin is lipid A, which, apart from few
exceptions (Mayer and Weckesser, 1984), shows very narrow structural relationship in
different bacterial genera. It consists of a P-1,6 linked disaccharide of glucosamine,
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covalently linked to 3-hydroxy-acyl substituents with 12 to 16 carbon atoms via amid and
ester bonds; these may be further esterified with saturated fatty acids. This hydrophobic
part of endotoxin adopts an ordered hexagonal arrangement, resulting in more rigid
structure compared with the rest of the molecule.
The supramolecular conformation of lipid A allows the optimal expression of
endotoxic activity. Lipid A, as an amphophilic molecule, behaves similarly to
phospholipids, which adopt different physical structures under different ambient
conditions, such as changes in temperature, pH, and charge state (Malchesky et al.,
1995).
The early work on the supramolecular structure of LPS has been reviewed by
Shands. It focused on the characterization of LPS particles with typical molecular
weights of 1 x 10 6 to 20 x 10 6 Da as estimated using physicochemical data on diffusion
coefficients and intrinsic viscosity. The investigation by Lipka et al (Lipka et al., 1988)
on the phase behavior of aqueous dispersions of lipid X, a pyrogen precursor, indicated
the critical micellar concentration to be 4 x 10 -5 mold, in a physiological saline solution;
the two pK values are pK 1 = 1.3 and pK2 = 8.2. The sugar phosphoryl moieties account
for the low pH value and can be considered as the functional groups that interact with
positively charged matrices in LPS removal, whereas the long-chain alkyl groups in lipid
A, as the hydrophobic tail, cause micelle formation and molecular aggregation.
(Malchesky et al., 1995). It was proposed that aggregation is governed by non—polar
interactions between neighboring alkyl chains as well as the bridges generated among
phosphate groups by bivalent cations (De Pamphilis, 1971; Wang and Hollingsworth,
1996)
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Electron microphotographs showed endotoxins as "snake-, donut- or rod-like
filaments and flat sheets" (Shands et al., 1967, Hannecart-Polorni et al., 1973). Modem
analytical methods, such as X-ray diffraction, FT-IR spectroscopy, neutron scattering,
NMR (Seydel et al., 1993) and molecular modeling (Kastowsky et al., 1992), revealed a
more detailed image of the three-dimensional organization of endotoxins. Although these
studies did not convey a uniform picture, it is evident that endotoxins aggregate in
lamellar, cubic and hexagonal inverted arrangements, such as micelles and vesicles with
diameters up to 0.1 p.m (Figure 2.3).

2.2 Biological Activity of Endotoxin
Endotoxins elicit their biological response by stimulating a reaction in the host cells, not
by killing them or by inhibiting cellular functions. Host cells of primary importance are
mononuclear cells, such as monocytes and macrophages (Galanos et al., 1993; Galanos et
al., 1992). For example, LPS-induced activation of macrophages results in the production
of bioactive lipids, reactive oxygen species, and especially peptide mediators, such as
tumor necrosis factor alpha (TNF), and several interleukins (Rietschel et al., 1994). These
potent hormone-like proteins can induce many of the typical endotoxin effects by acting
independently, in sequence, synergistically, or antagonistically. Clinical effects include
high fever, hypotension, and irreversible shock (Malchesky, 1995).
Endotoxins are pyrogenic; that is, they produce fever in man or other mammals.
Even if the bacteria are killed, their removal is essential for the safe parenteral
administration of products produced by natural sources or by recombinant DNA
technology. The sensitivity of mammals to LPS pyrogens is extraordinary. Contamination
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levels of less than 1 ng/ml elicit a strong fever response and can even result in death
(Nelsen, 1978).
Since endotoxins have profound toxicity, this forbade a safe use in man so far.
Therefore any superfluous endotoxin exposure must be strictly avoided to prevent
complications. This is especially true for medicaments applied intravenously.
In order to prevent the endotoxin-caused reactions, limitations were set as shown
in Table 2.1.
It needs to be pointed out that endotoxins may also have beneficial effects.
Endotoxins have been used in artificial fever therapy, to destroy tumors and to improve
nonspecifically the immune defense.
Normally, man comes into contact with endotoxins by drinking and swimming in
contaminated water (Sykora et al., 1980; Sykora and Keleti, 1981). In addition, man may
come into contact with endotoxin aerosols released by spray irrigation of contaminated
water via skin or eyes (Gerba and Goyal, 1981). Endotoxin concentration in water
sources closely related to daily life is shown in Table 2.2.
From Table 2.2 it can be seen that human beings can be obviously in contact with
endotoxins at any time and apparently can handle this without problems. As long as these
are in contact with the skin or digestive system, they are tolerated quite well.
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Table 2.1 Endotoxin limitation.

*Pearson, F. C. (1985) FDA Guideline for LAL End-Product Testing of Biologicals,
Parenteral Drugs, and Medical Devices. In Pyrogens: endotoxins, LAL testing, and
depyrogenation. Marcel Dekker, Inc. New York. p. 185.

Table 2.2 Endotoxin concentration in daily life source.

16
LPS is removed from the body over many weeks. It is degraded mainly in the
liver and subsequently excreted through the gut (Klein et al., 1985). Biliary excretion has
been identified as one route by which degraded LPS reaches the gut. Several mechanisms
of detoxification alleged to begin in the blood stream have been proposed, but conclusive
evidence for degradation and detoxification of LPS has yet to be presented.

2.3 Endotoxin and Protein Interaction
Endotoxin removal from protein solution encounters additional difficulty: endotoxins
have interaction with some proteins, even bind or form complexes with proteins, which
may be the target compounds of interest in recombinant biopharmaceuticals. That makes
endotoxin removal from protein solution more complicated.
Endotoxins show a remarkable capability to interact with proteins (Table 2.3).
One category of proteins is anti-endotoxin antibodies and proteineous endotoxin
receptors (Morrison et al., 1994). Molecular recognition can be assumed for such
interaction.
Many basic proteins (pI > 7) were reported to interact with endotoxin.
Electrostatic interactions can be assumed as the main driving force for such interaction.
While some studies supported that hydrophobic is the major driving force and only
limited ionic binding is involved (Ohno and Morrison, 1989).
Neutral protein, as hemoglobin and even acidic proteins, as serum albumin (pI <
7) (Roth et al., 1994; David et al, 1995) also were reported to interact with endotoxin.
The mechanisms of such interactions are not quite clear now. Generally it is assumed that
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hydrophobic interaction between protein and endotoxin is the main driving force. For
serum albumin, fatty acid binding domains might be involved (David et. al., 1995).

2.4 Endotoxin Removal Techniques
Methods for removing endotoxins depend on the molecular weight of the endotoxin, its
chemical properties, or both. The chemical decomposition of endotoxins with and acid,
alkali (Niwa et al., 1969), or oxidizing agent (Gherkin, 1975) is commonly practiced;
however, such methods cannot be used on blood or other biological products because of
their destructive nature.
Nondestructive approaches to endotoxin removal from aqueous solutions include
physical methods based on ultrafiltration by size and molecular weight differences
(Sweadner et al., 1977) and by adsorption to activated carbon and ion-exchange resins
(Nolazn et al., 1975; Pearson, 1985b).
Basically, four different approaches have been used to remove pyrogens from
aqueous solutions. These include (a) ultrafiltration, (b) adsorption to asbestos and
activated charcoal, (c) ion-exchange chromatography, and (d) affinity chromatography
(Table 2.4).
(a) Ultrafiltration. Ultrafiltration is a highly efficient method for removing
pyrogens from contaminated solutions. This technique is dependent on a difference
between the physical size of the pyrogen molecules and of the product being purified.
The contaminated solution is pressed through a finely porous polysulfone
membrane that retains high molecular—weight molecules and allows the
low-mecuarightlsoprugh.Selctinofapreltsizdpno
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the composition of the solution being purified and the state of aggregation of the
endotoxin molecules.
The degree of aggregation of endotoxin molecules is affected by the presence of
protein, due to endotoxin and protein interaction, divalent cations, chelating agents, and
detergents in the solution.
Endotoxin can be removed effectively from parenteral products with ultrafilters
with a 10,000 Da nominal molecular weight limit. In aqueous solutions, the majority of
endotoxin molecules aggregate into vesicles ranging from 300,000 to 1,000,000 Da
(Nelson, 1978).
Four filtration systems can be used in ultrafiltration: tangential-flow filtration,
stirred-cell filtration, hollow-fiber filtration, or thin-channel filtration. Conventional
filtration is not recommended because retained material builds up on the membrane
surface and causes a drastic reduction in flow rate and volume processing capacity
(Sharma, 1986). Ultrafiltration membranes can be cleaned and depyrogenated by
pumping NaOH (0.1-1.09 M) or HC1 (0.1 M) through the system. Most systems are
available for both general laboratory use and large-scale industrial use.
(b) Adsorption by asbestos and activated charcoal. The adsorption of pyrogens to
asbestos fiber and to activated charcoal are pyrogen elimination procedures that preceded
the use of ultrafiltration system (Nolazn et al., 1975). These systems, however, are
inconsistent, and highly dependent on the pyrogen concentration in the solution. They are
accompanied by high losses of the substance being purified. Due to its toxicity, in 1975,
FDA prohibited the use of asbestos fiber for pyrogen elimination from parenterals.
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Even though activated charcoal adsorption was effective in elimination pyrogens,
however, it was of limited value because it was difficult to remove the activated charcoal
from the purified solution and, as with any adsorption technique, there was a high risk of
adsorption of the desired product to the adsorbent.
(c) Endotoxin elimination using ion-exchange chromatography. Ion-exchange
chromatography is frequently used in the purification of products of recombinant DNA
technology. The advantages of this technique are its ability to process large sample
volumes, its high capacity, and the relatively mild conditions employed. Since endotoxins
are negatively charged due to the phosphate groups in its molecules, anion exchangers
were successfully used to remove endotoxins.
The use of DEAE-Sephadex for the removal of pyrogens was first described by
Grabner (Grabner, 1975). The pyrogens were irreversibly adsorbed on this resin during
the passage of a pyrogenic aqueous solution of high ionic strength (0.1 to 0.2 M).
Likewise, the anion-exchange resin DEAE-Sepharose CL-6B has been shown to
effectively adsorb pyrogens from a solution containing urokinase, which appeared in the
flow-through volume (Shibatani et al., 1983).
Cation exchangers do not appear to adsorb pyrogens.
(d) Endotoxin removal by affinity chromatography. Chemical adsorption of
endotoxins from whole blood or plasma is the only practical clinical treatment for septic
patients. In industry, adsorption has found wide use too. Sorption is based on either the
charge induced from phosphoryl groups or on hydrophobic interaction as a result of the
presence of lipid A groups (Malchesky et al., 1995).
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The cyclic lipophilic peptide antibiotic, polymyxin B sulfate, is known to
neutralize the biological activity of endotoxin (Rifkind, 1967; Corrigan et al., 1971;
Morrison et al., 1976) presumably due to its binding with high affinity to the toxic lipid A
moiety of endotoxins (Sharma, 1986). The hydrophobic components of polymyxin B can
be accounted for as coming from the isobutyl group in leucine and the phenyl group in
phenylalanine (Malchesky et al., 1995).
The bactericidal activity of the antibiotic polymyxin B against gram-negative
bacteria is based on the ability to deorganize the bacterial wall after insertion (Newton,
1956). The surface active cyclic peptide can break down endotoxin aggregates (Lopes
and Inniss, 1969). Owing to the interaction of polymyxin B with lipid A, the most
conservative part of endotoxin, it should be a group selective ligand with potential to
recognize endotoxins from different origins. Its use as a ligand in affinity sorbents
displays endotoxin clearance factors of > 10 5 from heavily contaminated culture filtrates
(1-10 µg/ml) of different gram-negative bacteria (Issekuzs, 1983). However, treating
endotoxemia with polymyxin B is difficult because it is toxic effect on the kidneys and
nervous system (Hanazawa et al., 1984).
One other affinity chromatography method was introduced by Minobe et al.
(Minobe et al., 1983). Histamine was immobilized to aminohexyl-Sepharose CL-4B with
glutaraldehyde treatment. This adsorbent has a high affinity for pyrogens from various
gram-negative bacteria. Results from studies examining the characteristics of the
immobilized histamine for pyrogen adsorption have suggested that the interaction
between the adsorbent and the pyrogen is both hydrophobic and ionic. Although the
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histamine sorbent was favored, it was switched to histidine owing to the biological
activity of histamine (Minobe et al., 1988).
An immunoaffinity chromatography in which the ligand is an antibody against the
component of interest may selectively remove the antigen while pyrogens remain in the
feed solution. Because of the high costs involve in the production of large quantities of
immobilized antibodies, their use is likely to remain restricted to those applications where
a low-cost ligand is not appropriate, and the compound to be isolated has a high value.
Hence, the technique has been used for the purification of pharmaceutical proteins such
as human interferon (Sbcher and Burke, 1980), vaccines, and antibodies.
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Table 2.3 Proteins that interact with endotoxin.

23
Table 2.4 Endotoxin removal methods.
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Figure 2.1 Structure of gram-negative bacteria cell wall and membranes.
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Figure 2.2 Structure of Bacteria lipopolysaccharide of Salmonella (Malchesky et al.,
1995).

.
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Figure 2,3 Structure of endotoxin aggregate (Millipore Co.).

CHAPTER 3

ENDOTOXIN DISAGGREGATION BY PROTEIN
AND PROTEIN CONCENTRATION EFFECT ON PROTEINLIPOPOLYSACCHARIDE BINDING AND ENDOTOXIN REMOVAL

3.1 Objective
Bacterial endotoxins are lipopolysaccharide (LPS) derived from the outer cell membranes
of Gram-negative bacteria (Hou and Zaniewski, 1990). Endotoxins are known to have
potent biological effects in man and in many animal species when administered
systemically (Issekutz, 1983). In biotechnology industry, Gram-negative bacteria are
widely used to produce recombinant DNA products, such as peptides and proteins.
Bacterial endotoxins have been recognized as a major cause of the pyrogenic reactions
that can be encountered during the administration of biological therapeutics. The removal
of these physiologically active agents from final bioproducts has always been a challenge
to the industry.
It is known that some proteins can disaggregate endotoxins and form complexes
with lipopolysaccharide (LPS). Some of such proteins have been identified, such as
lipoproteins (Schlichting et al., 1996) and monoclonal antibodies (Ziegler et al., 1991). It
is reported that hemoglobin not only can bind but also disaggregate endotoxins, and
enhance endotoxin activation of Limulus amebocyte lysate (LAL) in a concentration
dependent manner (Kaca et al., 1994; Roth et al., 1994). Variable effects of human serum
albumin (HSA) on endotoxin biological activity have also been reported. The biological
activity of endotoxin is changed in the presence of HSA, depending on HSA
concentration (Kaca et al., 1994).
27
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Nevertheless, whether other proteins also interact with endotoxin and
disaggregrate endotoxin, and how protein concentration affects protein-LPS binding and
endotoxin removal are unknown. In this study, an ultrafiltration method was used to
investigate interaction of protein and endotoxin and protein concentration effect on
protein-LPS binding and endotoxin removal. Protein samples (human hemoglobin,
bovine serum albumin, lysozyme, and cytochrome C, Table 3.1) at various concentrations
were incubated with endotoxin samples from Escherichia coli 026:B6 at a fixed
concentration. After incubation, the mixtures were filtered by 300,000 nominal molecular
weight cut-off (NMWCO) polysulfone ultrafiltration membrane. Limulus amebocyte
lysate (LAL) test was employed to detect endotoxin in the filtrates.

3.2 Materials and Methods
3.2.1 Materials

Proteins and endotoxin. Endotoxin from Escherichia coli 026:B6, human hemoglobin A0
(HbAo ferrous) and bovine serum albumin (BSA, fraction V), cytochrome C from bovine
heart, lysozyme from chicken egg white were purchased from Sigma.

Other materials. 0.l M endotoxin-free HC1, 0.1 M endotoxin-free NaOH, NaCl
(>99.0%), endotoxin-free water and endotoxin detection kit E-TOXATE were purchased
from Sigma. Ultrafree-CL polysulfone 300,000 NMWCO ultrafiltration membranes were
purchased from Millipore. All glassware used was autoclaved (series 300, Harvard/LTE)
for 1 hour and followed with heating in an oven (Thelco Model 16, Precision Scientific
Co.) at 175 ° C for 3 hours. All solution transfers were performed with endotoxin-free
devices.
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Endotoxin-free 0.9% NaCl solution was prepared with NaCl (>99.0%) and
endotoxin-free water. Protein solutions at various concentrations were prepared with
endotoxin-free 0.9% NaCl solution. 50 µg LPS /ml endotoxin solution was prepared with
endotoxin-free 0.9% NaCl solution.

Ultrafiltration membrane. Ultrafiltration membranes are rated on the basis of
molecular weight exclusion limits. Endotoxins that exceed the molecular weight
exclusion limit of a given membrane are retained on the surface of the membrane.
Normally, LPS molecules aggregate into vesicles with a molecular weight around 1
million Da (Pearson, 1985b). Therefore, pure endotoxin in aqueous solutions can not pass
through the ultrafiltration membranes rated at 300,000 molecular weight. If endotoxin
aggregates are broken-down by protein molecules and form much smaller protein-LPS
complexes as expected, the complexes will pass through the 300,000 NMWCO
membrane and endotoxin will be found in the filtrate. In this study, 300,000 NMWCO
polysulfone membranes were used to filter all samples (Figure 3.1). The filtrates were
subject to LAL test.

3.2.2 Endotoxin Detection
Endotoxin was detected using Limulus amebocyte lysate (LAL) test (Sigma, 1994).
Gelation was taken as the endpoint. Endotoxin from Escherichia coil 055:B5 was used as
the standard. For standard endotoxin detection, when endotoxin concentration was greater
than 0.06 Endotoxin Unit/ml, it formed solid gel and gave positive result; when
endotoxin concentration was less than 0.06 Endotoxin Unit/ml, it did not form solid gel
and gave negative result. Before the formation of the gel, the solution might be cloudy in
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the presence of endotoxin. The intensity of the cloudiness increases with the increase of
endotoxin concentration in the solution (Figure 3.3).

3.2.3 Pure Protein Study
0.9 ml protein preparations at various concentrations (Table 3.2, 3.3, 3.4, 3.5) were added
to l.5 ml sterile Eppendorf microcentrifuge tubes respectively, then 0.1 ml 0.9%
endotoxin free NaCl was added to each tube. The mixtures were incubated in a water bath
at 37 ° C for 30 minutes. After that the solutions were placed on 300,000 NMWCO
polysulfone ultrafiltration membranes and centrifuged at 1800g for 5 minutes. 0.1 ml
filtrate was taken from each solution and LAL test was employed to detect the endotoxin
in it (Figure 3.2).

3.2.4 Pure Endotoxin Study
0.1 ml 50 µg LPS/ml endotoxin solution was put into l.5 ml sterile Eppendorf
microcentrifuge tube, then 0.9 ml endotoxin free 0.9% NaCl solution was added to the
tube. The solution was incubated in a water bath at 37 ° C for 30 minutes. The following
steps were the same as those in the pure protein study (Figure 3.2).

3.2.5 Protein-LPS Binding Study
0.9 ml protein preparations at various concentrations (Table 3.6, 3.7, 3.8, 3.9) were added
to l.5 ml sterile Eppendorf microcentrifuge tubes respectively, then 0.1 ml 50 µg LPS/ml
endotoxin solution was added to each tube. The mixtures were incubated in a water bath
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at 37 ° C for 30 minutes. The following steps were the same as those in the pure protein
study (Figure 3.2).

3.3 Results and Discussion
3.3.1 Pure Hemoglobin Study
Pure human hemoglobin A o (HbA o ) solutions were filtered by 300,000 NMWCO
membranes and the filtrates were tested by LAL method. The results are shown in Table
3.2. When HbAo concentrations were 19.2 µg/ml, 38.3 µg/ml and 75.6 µg/mg, the LAL
test gave negative results. It suggested that the filtrates of pure HbA o were endotoxin free.

3.3.2 Pure Albumin Study
Pure bovine serum albumin (BSA) solutions were filtered by 300,000 NMWCO
membranes and the filtrates were tested by LAL method. The results are shown in Table
3.3. When BSA concentrations were 6.8 µg/ml, 10.2 µg/ml and 20.4 µg/ml, the LAL test
gave negative results. It suggested that the filtrates of pure BSA solutions were endotoxin
free.

3.3.3 Pure Lysozyme Study
Pure chicken egg white lysozyme solutions were filtered by 300,000 NMWCO
membranes and the filtrates were tested by LAL method. The results are shown in Table
3.4. When lysozyme concentrations were 28.1 µg/ml, 56.3 µg/ml and 112.5 µg/ml, the
LAL test gave negative results. It suggested that the filtrates of pure BSA solutions were
endotoxin free.
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3.3.4 Pure Cytochrome C Study
Pure bovine heart cytochrome C solutions were filtered by 300,000 NMWCO membranes
and the filtrates were tested by LAL method. The results are shown in Table 3.5. When
cytochrome C concentrations were 20.1 µg/ml, 50.7 µg/ml and 101.3 µg/ml, the LAL test
gave negative results. It suggested that the filtrates of pure BSA solutions were endotoxin
free.

3.3.5 Pure Endotoxin Study
Pure endotoxin solution was filtered by a 300,000 NMWCO membrane and the filtrate
was tested by LAL method. The filtrate was clear in the presence of LAL lysate and
LAL test gave negative result. This indicated that the endotoxin was in an aggregated
state and could not pass through the membrane, so no endotoxin was found in the filtrate.

3.3.6 HbA o -LPS Binding Study
The HbA o -LPS mixtures were filtered with 300,000 NMWCO membranes after
incubation. The filtrates were tested by LAL method and the results are shown in Table
3.6. In this study, the HbA o concentration in the mixture was increased while the
endotoxin concentration was kept the same at 5 µg LPS/ml in every mixtures. It was
observed that when HbA o concentration was increased, the cloudy intensity of the
filtrate-LAL solution increased too. When HbA 0 concentration was 19.2 µg/ml and 38.3
µg/ml in the HbA o-LPS mixture, the filtrates of the mixtures formed slightly cloudy
solutions in the presence of LAL lysate, and the test gave negative results. When HbAo
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was at 76.5 µg/ml in the HbA o -LPS mixture, the filtrate of the mixture formed a solid gel
in the presence of LAL lysate, and the test gave a positive result.
The physical meanings of above results may be explained as follows. Pure
endotoxin is usually in an aggregated state with molecular weight around 1 million Da
and is retained by a 300,000 NMWCO membrane. If a small amount of hemoglobin is
added to the pure endotoxin solution, the protein molecules break the endotoxin
aggregates and form protein-LPS complexes with endotoxin subunits. These complexes
have much smaller size than the original pure endotoxin aggregates and can easily pass
the 300,000 NMWCO membrane. Therefore, the endotoxin content in the protein-LPS
complexes in the filtrate result in a cloudy solution in the presence of LAL lysate. If the
hemoglobin concentration is increased in the protein-LPS mixture, more protein-LPS
complexes will form and pass the membrane. The intensity of the cloudiness of the
filtrate-LAL solution increases as well. If the hemoglobin concentration is increased
further, it will reach a point that the filtrate forms a solid gel with LAL lysate, i.e., a
positive LAL test result.

3.3.7 BSA-LPS Binding Study
The BSA-LPS mixtures were filtered with 300,000 NMWCO membranes after
incubation. The filtrates were tested by LAL method and the results are shown in Table
3.7. When BSA concentration was 6.8 µg/ml and 10.2 µg/ml in the mixtures, both of
them formed clear solutions with LAL lysate and the test gave negative results. This
means no endotoxin was detected in the filtrates. When BSA was at 20.4 µg/ml in the
mixture, it formed solid gel with LAL lysate and the test gave a positive result. These
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results may also be explained by the above discussions about HbA o . It is noticed from
Table 3.6 and Table 3.7 that BSA is more effective in disaggregating endotoxin at a
lower concentration than HbA o . One explanation is that a BSA molecule binds more
endotoxin subunits than a HbA o molecule does in the solution. The exact mechanism is
not well understood yet.

3.3.8 Lysozyme-LPS Binding Study
The lysozyme-LPS mixtures were filtered with 300,000 NMWCO membranes after
incubation. The filtrates were tested by LAL method and the results are shown in Table
3.8. When lysozyme concentrations were 28.1 µg/ml, 56.3 µg/ml, 112.5 µg/ml in the
mixtures, all of them formed cloudy solutions with LAL lysate and the test gave negative
results. If endotoxin was disaggregated by lysozyme to form small aggregates, the small
aggregates would pass through ultrafiltration membrane and would be detected. The
negative LAL test results mean almost no endotoxin was found in the filtrate. That
indicated endotoxin was not disaggregated by lysozyme.

3.3.9 Lysozyme-LPS Binding Study
The cytochrome C-LPS mixtures were filtered with 300,000 NMWCO membranes after
incubation. The filtrates were tested by LAL method and the results are shown in Table
3.9. When cytochrome C concentrations were 20.1 µg/ml, 50.1 101.3 µg/ml in the
mixtures, all of them formed clear solutions with LAL lysate and the test gave negative
results. If endotoxin was disaggregated by cytochrome C to form small aggregates, the
small aggregates will pass through ultrafiltration membrane and were detected. The
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negative LAL test results means almost no endotoxin was found in the filtrates. That
indicated endotoxin was not disaggregated by cytochrome C.

3.4 Conclusions
These results demonstrate that some proteins (hemoglobin and albumin in this study) can
break endotoxin aggregates. Also concentration of the protein has a significant effect on
the amount of endotoxin disaggregated and the amount of protein-LPS complex formed.
Ultimately, protein concentration will affect the rate of endotoxin removal by
ultrafiltration membrane processes. Knowing this mechanism is very important to
ultrafiltration membrane process design for removing endotoxin from biological
solutions.
The above results also show that chicken egg white lysozyme and bovine heart
cytochrome C did not disaggregate endotoxin, that is, these two proteins did not break
endotoxin into small fragments.
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Table 3.1 Properties of proteins and endotoxin.

Table 3.2 LAL test results of pure HbA o solutions.
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Table 3.3 LAL test results of pure BSA solutions.

Table 3.4 LAL test results of pure lysozyme solutions.
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Table 3.5 LAL test results of pure cytochrome C solutions.

Table 3.6 LAL test results of HbA o -LPS binding study.
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Table 3.7 LAL test results of BSA-LPS binding study.

Table 3.8 LAL test results of lysozyme-LPS binding study.
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Table 3.9 LAL test results of cytochrome C-LPS binding study.
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Figure 3.1 Molecular structure of hydrophobic polysulphone membrane (Howell et al.,
1993).

Figure 3.2 Schematic diagram of experimental procedure. The experimental procedure:

protein/LPS mixtures at various concentration ratios were incubated at 37 ° C for 30
minutes. After incubation, the mixtures were applied to ultrafiltration. The filtrate was
applied to gelation LAL test.
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Figure 3.3 Principle of Limulus amebocyte lysate (LAL) test.

CHAPTER 4

SIZE EXCLUSION HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
(SE-HPLC) STUDIES ON ENDOTOXIN DISAGGREGATION
BY BOVINE SERUM ALBUMIN (BSA)

4.1 Objective
Endotoxin subunits have molecular weights of 10,000 or less, depending on the
composition of the solution in which they are present (Gerba and Goyal, 1981).
Aggregated forms of endotoxin range from 300,000 to 1,000,000 daltons (Brown and
Fuller, 1993; Abramson et al., 1981; Sweadner et al., 1977; Hannecart-Pokomi et al.,
1973). In Chapter 5 it is shown such endotoxin aggregation is facilitated by cations in
protein solution; and the aggregation is obliterated by protein, such as hemoglobin and
albumin, in a protein concentration dependent manner. It is hypothesized that an
equilibrium exists between aggregated endotoxin and disaggregated endotoxin in the
presence of protein. Using ultrafiltration method, previous studies described in Chapter 3
have shown that protein concentration has a significant impact on the equilibrium
shifting: as protein concentration increased, the equilibrium was disturbed and shifted to
form more disaggregated endotoxin. However, some questions are still unsolved, that is,
what is the endotoxin disaggregation rate? Is it partially or completely disaggregated.
Before and after disaggregation, how do endotoxin aggregated forms change and what
elements affect such disaggregation.
Studies of proteins that interact with LPS have used a variety of methods to
demonstrate and quantify such interaction. For example, fluorescent-labeled LPS was
used to study LPS binding to lipopolysaccharide-binding protein (LBP) (Tobias et al.,
43
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1995; Yu and Wright, 1996). Other nondestructive methods of analysis, such as native
gel electrophoresis was used with biosynthetically isotope labeled LPS (Juan et al.,
1995). Membrane ultrafiltration was used to study the effect of protein concentration on
protein and LPS binding as described in Chapter 3.
Size-exclusion high-performance liquid chromatography (SE-HPLC) is another
nondestructive method for studying protein and LPS interaction. The advantage of the
size-exclusion HPLC technique is that it neither structurally alters the LPS by adding a
fluorescent adduct nor disrupts the native state of the proteins and LPS. In addition, the
size-exclusion HPLC method can measure the size of LPS aggregates, determine an
exclusion limit, and resolve protein from LPS.
This is the first effort at using size exclusion high performance liquid
chromatography (SE-HPLC) combined with UV absorbance detection to study endotoxin
disaggregation. SE-HPLC method was used to investigate LPS disaggregation in the
presence of bovine serum albumin (BSA). Ultraviolet (UV) absorbance was employed as
the detection method to obtain the chromatography profile. This is the most elucidative
way to demonstrate LPS disaggregation. Protein and endotoxin mixture samples at
various concentration ratios, which were incubated at 37 ° C for 30 min or directly set at
room temperature without incubation, are analyzed with SE-HPLC. Size exclusion
chromatography separates molecules on the basis of molecular size, that is, molecules are
eluted in order of decreasing molecular size. If endotoxin is disaggregated by protein to
form smaller size aggregates, such smaller aggregates will be eluted at longer retention
times, in comparison with the original endotoxin aggregates. From the chromatographic
profile, we can see that the area of the first LPS aggregate peak, which is produced by the
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larger aggregates, will decrease under the effect of BSA and move to longer retention
time. The area of LPS peaks, which are smaller than the first peak and eluted at longer
retention times, will increase. Under certain conditions, new peak groups of smaller size
species formed.

4.2 Materials and Methods
4.2.1 Materials
Glassware. All glassware used was sterilized in an autoclave (Series 300, Harvard/LTE)
for 1 hour and followed with heating in an oven (Thelco Model 16, Precision Scientific
Co., Chicago, IL) at 175 ° C for 3 hours. All solution transfers were performed by
endotoxin-free device. Sterile, disposable plasticware was used to prevent endotoxin
contamination.
Reagents. Endotoxin-free water from BioWhittaker (BioWhittaker Inc.,
Walkersville, MD) was used for endotoxin dilution and all sample solution preparations.
Endotoxin-free water produced by Milli-Q water system (Millipore Corporation,
Bedford, MA) was used for high performance liquid chromatography (HPLC) mobile
phase preparation. Endotoxin from Escherichia coil 026:B6, bovine serum albumin
(BSA, fraction V, cell culture reagent), NaCl (molecular biology reagent) were from
Sigma (Sigma Chemical Co., St. Louis, MO). Bovine serum albumin and endotoxin
solutions were prepared with endotoxin-free 0.15 M NaCI solution.
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4.2.2 Pure LPS Study
Pure LPS solution was prepared by placing 0.25 ml LPS stock solution of 1 mg/ml in a
NaCl. 15 ml endotoxin-free sterile polystyrene tube; then adding 0.75 ml endotoxin-free 0.15 M

Pure LPS study without incubation: After pure LPS solution was prepared, 1 ml
sample were taken from the tube containing pure LPS solution, and then transferred to
the HPLC sampler vials for HPLC analysis.
Pure LPS study with incubation: After pure LPS solution was prepared, the tube
containing LPS solution was incubated at 37 ° C in a water bath for 30 min. 1 ml sample
was taken from the tube containing pure LPS solution, and then transferred to HPLC
sampler vials for HPLC analysis (Figure 4.1).

4.2.3 Pure Protein Study
Bovine serum albumin (BSA) stock solution at various concentrations was prepared by
serial dilution with endotoxin-free 0.15 M NaCl (Table 4.1). Stepwise dilution was used
to make dilution accurately. 0.5 ml BSA solution at various concentrations was taken and
put into 15 ml endotoxin-free sterile polystyrene tube individually. Then 0.5 ml
endotoxin-free 0.15 M NaCl was added to each tube to prepare pure BSA solution. The
concentrations of these BSA solutions were 0.25, 0.5, 1, 2 and 4 mg/ml (Table 4.2).
Pure BSA study without incubation: After pure BSA solutions were prepared, 1
ml samples were taken from all solutions, and then transferred to HPLC sampler vials for
HPLC analysis.
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Pure BSA study with incubation. After pure BSA solutions were prepared, the
tubes containing BSA solutions were incubated at 37 ° C in a water bath for 30 min. 1 ml
samples were taken from all solutions, and then transferred to HPLC sampler vials for
HPLC analysis (Figure 4.1).

4.2.4 BSA-LPS Interaction without Pre-Incubation
BSA solution at various concentrations was prepared by series dilution with endotoxinfree 0.15 M NaCl (Table 4.2). Stepwise dilution was used to make dilution accurately.
0.5 ml BSA solution at various concentrations was taken and put into a 15 nil
endotxi-frslpyentubidval.025mLPSsoutina1g/lwdeto
each tube, then 0.25 ml endotoxin-free 0.15 M NaCl was added to each tube to prepare
BSA and LPS mixtures at various concentration ratios (Table 4.3). In such BSA and LPS
mixtures, the BSA concentration was 0.25, 0.5, l, 2 and 4 mg/ml, while endotoxin
concentration is the same for each mixture solution, that is 025 mg/ml (Table 4.4).
After BSA and LPS mixtures were prepared, 1 ml samples were taken from all
mixtures and transferred to HPLC sampler vials for HPLC analysis (Figure 4.2).

4.2.5 BSA-LPS Interaction with Pre-Incubation
BSA solution at various concentrations was prepared by series dilution with
endotxi-fr0.15MNaCl(Tbe42);suchtpwidlonasuetmkdilon
accurately. 0.5 ml BSA solution at various concentrations was taken and put into a 15 ml
endotoxin-free sterile polystyrene tube individually. 0.25 ml LPS solution at l mg/ml was
added to each tube, then 0.25 ml endotoxin-free 0.15 M NaCl was added to each tube to
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prepare BSA and LPS mixtures at various concentration ratios (Table 4.3). In such BSA
and LPS mixtures, the BSA concentration was 0.25, 0.5, l, 2 and 4 mg/ml, while
endotoxin concentration is the same for each mixture solution, that is 0.25 mg/ml (Table
4.4).
After BSA and LPS mixtures were prepared, the tubes containing the mixture
solutions were incubated at 37 ° C in a water bath for 30 min. 1 ml samples were taken
from all mixtures and transferred to HPLC sampler vials for HPLC analysis (Figure 4.1).

4.2.6 Size Exclusion High Performance Liquid Chromatography (SE HPLC)
-

The basis for the separation mechanism in size exclusion chromatography is 'sieving'.
Chromatographic separations based on size are achieved by controlling the size of the
pores in the stationary phase. If the molecules are too large for the pores, they never enter
the gel and move outside the gel bed with the eluting solvent. Thus, the very large
molecules in a mixture move the fastest through the gel bed. The smaller molecules,
which can enter the gel pores, are retarded and move more slowly through the gel bed.
Molecules of intermediate size will be partially excluded from the pores and can be
separated from each other based on the fractional extent of their exclusion (Figure 4.3). In
size exclusion chromatography, molecules are, therefore, eluted in order of decreasing
molecular size (Figure 4.4).
Hewlett-Packard series II 1090 HPLC system (Hewlett-Packard Co., Wilmington,
DE) was used to analyze LPS disaggregation in protein solutions. The size exclusion
column, TSK-GEL G2000SWXL, was from TosoHaas (TosoHaas, Montgomeryville,
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PA). Diode array detector was used for determination the UV absorbance of column
eluents.
BSA and LPS mixture solutions at various concentration ratios (Table 4.4), which
were pre-treated without incubation or with incubation, were analyzed by HPLC on a
TosoHaas TSK-GEL G2000SWXL column in an isocratic 0.l M phosphate buffer at pH
6.7. The buffer consisted of 0.05 M KH 2PO4, 0.05 M Na2HPO4, 0.l M Na2SO4 and 0.05
% NaN3. HPLC assay was performed at flow rate of I ml/ml. The injection volume was
25 pl. Diode array detector was set at 260 nm for detection UV absorbance.

4.3 Results and Discussion
4.3.1 Pure LPS Study
To investigate how LPS was disaggregated by BSA, it is necessary to examine how the
LPS molecule changes after being mixed with BSA. Therefore a study of pure LPS with
SE-HPLC was performed. Since in size exclusion chromatography molecules are eluted
in order of decreasing molecular size. The size distribution of pure LPS aggregates can be
determined. If LPS was composed of uniform size aggregates, it would elute as one peak.
If LPS was composed of various size aggregates, it would elute as different size peak
complexes, and the eluting peaks would be detected at different retention times. The
larger size aggregates would move fastest through the gel bed and elute first. The smaller
molecules, which can enter the gel pores, would be retarded and move more slowly
through the gel bed, and be eluted later.
From the chromatography we can see that pure LPS was composed of different
size aggregates. The pure LPS eluted as several peaks, detected at different retention
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times. When LPS alone was chromatographed on TEK-GEL G2000SWXL, at the
concentrations employed, detected by absorbance at 260 nm, two peaks were detected.
The peak eluted at 6.9 min was the first peak group, another peak eluted at 9.3 min was
the second peak group (Figure 4.5). Further regardless of pre-incubation or not, pure LPS
peaks were the same.

4.3.2 Pure Protein Study
Using the ultrafiltration membrane method, BSA and LPS interaction was studied in the
previous chapter. The study showed that endotoxin was disaggregated by BSA.
According to that study, when pure BSA solutions were filtered by 300,000 nominal
molecular weight cut-off (NMWCO) membrane, and the filtrates tested with LAL
method, the test gave negative results. First, this indicated that pure BSA was endotoxin
free; second, it showed that BSA molecules were small enough to pass through the
membrane. When pure LPS solution was filtered through a 300,000 NMWCO membrane
and tested with LAL method, the LAL test gave negative result. This indicated that LPS
was too large to pass through the membrane, so no LPS was detected in the membrane
filtrate. But when BSA and LPS mixtures were filtrated with 300,000 NMWCO
membranes and tested with LAL method, the LAL test gave positive results at certain
BSA/LPS ratio. This indicated LPS was disaggregated by BSA and passed through the
membrane. To further investigate how LPS size changed after disaggregation by BSA,
size exclusion liquid chromatography (SE-HPLC) method was developed on the basis of
previous qualitative studies.
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To investigate how LPS is disaggregated by BSA, it is essential to know BSA
status before it is mixed with LPS. As described above, BSA preparations at various
concentrations were injected for HPLC assay (Table 4.2).
From the chromatogram at Figure 4.6 we can see, first, at the concentrations of 4,
2, 1 and 0.5 mg/ml, pure BSA eluted at 8.1 min and 9.7 min. At concentration of 0.25
mg/ml, pure BSA peak only was detected at 9.7 min at absorbance 260 nm, as shown in
Figure 4.5. Second, regardless of pre-incubation or not, pure BSA peaks were the same.

4.3.3 Endotoxin Disaggregation by BSA
From the previous chapter, it is known that BSA and endotoxin have interaction. Using
ultrafiltration membrane method, it can be seen that endotoxin was disaggregated by
BSA. Such disaggregated endotoxin could pass through 300,000 molecular weight cut off
membrane and was detected by gelation Limulus Ambocyte Lysate (LAL) test. But such
quantitative study can not demonstrate 1) endotoxin existing form changed after such
disaggregation 2) endotoxin disaggregation rate 3) endotoxin disaggregation
completeness.
Using size exclusion high performance chromatography (SE-HPLC) to
demonstrate BSA interaction with LPS, advantage was taken of the significant
differences in molecular weight of these two molecules, Whereas LPS exists as an
aggregated macromolecular structure with molecular weight of the order of 10 6 or greater,
BSA is a medium molecular mass protein with a molecular mass of about 67,000 Da.
These molecules are readily separable on columns of TSK-GEL G2000SWXL (Tosohaas
Co., Montgomeryville, PA). When LPS alone was chromatographed using TEK-GEL
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G2000SWXL, at the concentrations employed was detected by absorbance at 260 nm,
two peaks were eluted. The peak eluted at 6.9 min was the first peak group and another
eluted at 9.3 min was the second peak group, as shown in Figure 4.6. When BSA was run
individually, it eluted at 8.l min and 9.7 min, at the concentration 4, 2, 1 and 0.5 mg/ml.
While at concentration 0.25 mg/ml, the eluted peak at 8.1 min was very small.
As described above, albumin disaggregated endotoxin study was performed at a
BSA to endotoxin concentration ratio of 16 (Table 4.4), that is, BSA concentration in the
mixture solution was 4 mg/ml, endotoxin concentration in the mixture solution was 0.25
mg/ml. From the chromatogram of pure LPS, pure BSA, BSA and LPS mixture (Figure
4.7), it can be seen, comparing with the pure endotoxin profile, the peak group 1 of the
mixture partially shifted from retention time 6.9 min to a longer retention time; the peak
group 1 area of the mixture decreased distinctly (Figure 4.12, Figure 4.13, Figure 4.14);
the peak group 2 area of the mixture increased (Figure 4.15); the peak group 3 area of the
mixture increased (Figure 4.16); and a new peak group, which was named peak group 4,
formed only in the mixture solution (Figure 4.17)
First, from the result it is concluded that endotoxin was disaggregated by BSA.
The disaggregation led to the formation of smaller size endotoxin fragments. Because
size exclusion chromatography separates molecules in decreasing order of molecular size,
Those fragments eluted at longer retention time. So from the chromatography profile and
analyzing figures, one can see peak area of peak group 1 decreased, while peak area of
peak group 2 and 3 increased. Furthermore, due to such disaggregation, a smaller size
peak group, which was named peak group 4, formed.
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Second, from these results, it is concluded that such BSA and endotoxin
interaction caused BSA and endotoxin binding. Pure BSA has a peak at 9.7 min. Pure
endotoxin has a peak at 9.3 min. The two peaks can not be separated by the column
employed. So we totaled the peak area of peak group 3 of pure BSA and pure endotoxin,
and compared it with peak group 3 area of BSA and endotoxin mixture. Comparing peak
area sum of pure BSA and pure endotoxin with BSA and endotoxin mixture (Figure
4.16), we can see the peak area of BSA and endotoxin mixture is larger than area sum of
pure BSA and pure endotoxin. Therefore we concluded that the BSA and endotoxin
interaction led to BSA and endotoxin binding. Another experiment, which was carried
out at without incubation condition for the same BSA and endotoxin concentration, also
assured such conclusion (Figure 4.23).
Third, from the result we can see peak 1 of pure endotoxin was the major peak
that was disaggregated (Figure 4.7, Figure 4.18). After the disaggregation, the peak area
of the BSA and endotoxin mixture was only 17.2% of the original pure endotoxin peak
area (Figure 4.29). Also we can see peak 1 was not completely disaggregated, some
remaining part still can be found under the experiment conditions (Figure 4.7, Figure
4.14, Figure 4.29).

4.3.4 Effect of BSA Concentration on Endotoxin Disaggregation
To examine the question further, BSA concentration was varied in BSA and endotoxin
mixture solutions to investigate the effect of BSA concentration on endotoxin
disaggregation.
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From the previous chapter, it is known that BSA concentration has effects on
BSA and endotoxin interaction. Using ultrafiltration membrane method, one can see that
as BSA concentration increased in the BSA and endotoxin mixture solutions, more
endotoxin was disaggregated by BSA. Therefore more disaggregated endotoxin passed
through 300,000 nominal molecular weight cut off (NMWCO) membrane. As the amount
of endotoxin passing through the membrane above the detection limit of gelation Limulus
Amebocyte Lysate (LAL) test, the endotoxin can be detected. This study can not
demonstrate 1) at different BSA concentrations in the BSA-endotoxin mixture, what is
the difference between endotoxin aggregate sizes? 2) at what BSA concentration in the
BSA and endotoxin mixture, or at what BSA and endotoxin concentration ratio,
endotoxin is disaggregated significantly.
First, from the chromatography profile (Figure 4.8, Figure 4.9) one can see that at
different BSA concentrations in the BSA-endotoxin mixture solutions, or at different
BSA/LPS concentration ratios in the mixture solutions, the peak area changes for each
peak group were different. The more BSA concentration in BSA and endotoxin mixture,
or the higher the BSA/LPS concentration ratio, the smaller the peak group 1 area (Figure
4.12, Figure 4.13, Figure 4.14), the larger the peak group 2 area (Figure 4.15), the larger
the peak group 3 area (Figure 4.16), and the larger the peak group 4 area (Figure 4.17).
AS is defined as peak area of BSA and LPS mixture minus corresponding peak area sum

concentration increased, AS of PG1 decreased, AS of PG2, PG3 and PG4 increased. The
peak area percentage was defined as percentage of mixture peak area divided by sum
peak area of pure BSA and pure endotoxin. For instance, at BSA concentration 0.25, 0.5,
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1, 2, 4 mg/ml in the mixture, the peak area percentage of peak group 1 is 72.3, 42.1, 18.4,
15.2 and 17.2% respectively (Figure 4.29). Those results showed as BSA concentration
increased, more LPS was disaggregated, more smaller size endotoxin fragments formed,
therefore peak area of peak group that eluted at shorter retention time decreased, for
example, peak group 1. Peak area of peak group that eluted at longer retention time
increased, for example, peak group2, 3 and 4.
Also, from the results we can see when BSA concentrations were 2 mg/ml and 4
mg/ml in the mixture solution, or at BSA/LPS concentration ratio of 8 and 16, the LPS
disaggregation was significant. From the above study it is known that more LPS was
disaggregated by BSA, the greater mixture peak group 1 area decreased, the higher was
the mixture peak group 4.
As defined above, the peak area percentage is mixture peak area divided by peak
area sum of pure BSA and pure endotoxin, then multiplied by 100. For peak group 1,
when BSA at 0.25 and 0.5 mg/ml, the peak area percentage is 72.3% and 42.1%, as BSA
concentration increased to 2 and 4 mg/ml, the peak area percentage decreased to 15.2%
and 17.2% (Figure 4.29).
For peak group 4, at BSA concentration at 0.25 mg/ml, if assumed peak area as 1,
when BSA concentration increased to 2 and 4 mg/ml, the peak area was 53.0 and 63.2.
This means that, as BSA concentration increased, the peak group 4 area increased by
factor of 53 and 63 times respectively.
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4.3.5 Effect of Sample Pre-Incubation on Endotoxin Disaggregation
The experiment was designed to investigate pre-incubation influence on BSA and
endotoxin interaction. As described above, the study was performed at various BSA and
endotoxin concentration ratio as shown in Table 4.4. In contrast, a set of control
experiments without incubation was carried out. All the experiment procedures were the
same except no sample incubation was done before HPLC assay.
As described in `Endotoxin Disaggregation by BSA', after the endotoxin
disaggregation by BSA, the peak group 1 of the mixture partially shifted from retention
time 6.9 min to longer retention time. The peak group 1 area of the mixture decreased
distinctly (Figure 4.8, Figure 4.9, Figure 4.14). The peak group 2 area of the mixture
increased (Figure 4.15). The peak group 3 area of the mixture increased (Figure 4.16).
New peak group, which was peak group 4, formed only in mixture solutions (Figure 4.17,
Figure 4.12, Figure 4.13).
Also from Section 4.3.4, it is known that more endotoxin was disaggregated in
BSA and endotoxin mixture, the smaller the peak group 1 area (Figure 4.29, Figure 4.14),
the larger the peak group 2 area (Figure 4.15), the larger the peak group 3 area (Figure
4.16), the larger the peak group 4 area (Figure 4.17, Figure 4.12, Figure 4.13).
Comparing the chromatography profiles with and without incubation at each
BSA/LPS concentration ratio (Figure 4.8, Figure 4.9, Figure 4.10, Figure 4.11), it is clear
that incubation will increase the LPS disaggregation. Under incubation condition, peak
group 1 area is smaller than that without incubation (Figure 4.25), and the peak
percentage is smaller than that without incubation (Figure 4.29). For example, at
BSA/LPS concentration ratio equaled to 1, without incubation, the peak percentage of
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peak group 1 was 98.1%; while with incubation, the peak percentage of peak group 1 was
72.3% (Figure 4.29). That means that more LPS was disaggregated with incubation. Peak
group 2 and 3 area was larger than that without incubation, that means that more LPS was
disaggregated and formed binding with BSA (Figure 4.26, Figure 4.27). Also only with
incubation, a new peak group, peak group 4, formed (Figure 4.28, Figure 4.12, Figure
4.13). In contrast, without incubation, no peak group 4 existed.
From AS, which is defined as peak area of BSA and LPS mixture minus

in Figure 4.18 and Figure 4.24, when BSA concentration increased, at with preincubation condition, AS of PG1 is less, and AS of PG2, PG3 and PG4 are larger than that
without incubation.
From the results of LPS disaggregation without incubation, it is also noticed that
LPS disaggregation started right after endotoxin was mixed with BSA, no matter whether
the BSA and LPS mixture was incubated or not. Without incubation, such disaggregation
is not obvious at low BSA concentration, i. e. 0.25, 0.5, 1 mg/ml, but as protein
concentration increased in the mixture solutions, LPS disaggregation is easily detectable.
Without incubation, LPS disaggregation is mainly due to the disaggregation of peak
group I. With incubation, disaggregation is detectable even at low BSA concentrations.
This fact, from another view, gave evidence that incubation improved LPS
disaggregation.
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4.3.6 Discussion
The mechanism of BSA and endotoxin interaction is not clear yet. BSA is a basic protein
(p1 < 7). Some studies suggested that interaction between basic protein and endotoxin
involves hydrophobic interaction. Fatty acid binding domains might be involved also
(David et al., 1995).
Due to the phosphate group in endotoxin molecule, at pH above 2, the endotoxin
is always negatively charged. The investigation by Lipka et al (Lipka, et al 1988) on the
phase behavior of aqueous dispersions of lipid X, a pyrogen precursor, indicated the
critical micellar concentration to be 4 x 10 -5 mol/L in a physiological saline solution. The
two pK values are pK 1 = 1.3 and pK2 = 8.2. The sugar phosphoryl moieties account for
the low pH value. The long-chain alkyl groups in lipid A, as the hydrophobic tail, cause
micelle formation and molecular aggregation. (Malchesky et al., 1995). Normally
endotoxin exists in vesicles. Under the hydrophobic interaction, the vesicles are broken
into micelles.

4.4 Conclusions
The results of this study have shown that bovine serum albumin can disaggregate
endotoxin. Such disaggregation was affected by BSA concentration. As BSA
concentration increased, more endotoxin was disaggregated, and more smaller size
endotoxin fragments were formed. Also pre-incubation of BSA and endotoxin mixture
facilitated such endotoxin disaggregation. At the same BSA concentration in the mixture,
pre-incubation caused more endotoxin to be disaggregated.
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The results are significant for endotoxin removal process design. For endotoxin
removal design, not only should solution composition be considered, but also
concentration of each component be taken into account. Especially for membrane process
or chromatography process taking advantage of endotoxin molecular size, from this
study, it is clear that at different concentration composition, the endotoxin aggregate size
will vary. Such endotoxin size changes will affect endotoxin removal significantly.
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Table 4.1 BSA stock solution preparation.

Table 4.2 Pure BSA solution preparation.
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Table 4.3 BSA and endotoxin mixture solution preparation.
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Table 4.4 Composition of BSA and endotoxin mixture solutions.
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Figure 4.1 Illustration of pre-incubated sample study.
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Figure 4.2 Illustration of without pre-incubated sample study.
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Figure 4.3 Illustration of size exclusion liquid chromatography procedure.
Size exclusion chromatograph. Open circles represent porous gel molecules; large solid
circles represent molecules too large to enter the gel through the pores, and smaller solid
circles represent molecules capable of entering the gel pores.
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Figure 4.4 Illustration of size exclusion chromatogram.
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Figure 4.5 Chromatograms of pure LPS sample at a concentration of 0.25 mg/ml.
PG1: Peak group 1, retention time, Tr = 6.0 —7.7 minutes.
PG2: Peak group2, retention time, Tr = 8.0 —8.8 minutes.
PG3: Peak group3, retention time, Tr = 9.3 —9.7 minutes.
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Figure 4.6 Chromatograms of pure BSA samples at various injecting concentrations.
A: BSA concentration, CBSA= 4 mg/ml; B: BSA concentration, CBSA = 2 mg/ml;
C: BSA concentration, CBSA =1 mg/ml; D: BSA concentration, C BSA = 0.5 mg/ml;
E: BSA concentration, C BSA = 0.25 mg/ml.
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Figure 4.7 Chromatograms of LPS disaggregation by BSA (see 4.3.3).
A: Pure LPS concentration, C LPS = 0.25 mg/ml;
B: Pure BSA concentration, C BSA = 4 mg/m1;
C: BSA and LPS concentration ratio, C BSA/CLPS = 16.
PG1: Peak group 1, retention time, Tr = 6.0 —7.7 minutes.
PG2: Peak group2, retention time, Tr = 8.0 —8.8 minutes.
PG3: Peak group3, retention time, Tr = 9.3 —9.7 minutes.
PG4: Peak group4, retention time, Tr = 10.5 - 12.9 minutes.
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Figure 4.8 Chromatograms of BSA and LPS mixture samples, pure LPS sample and pure
BSA samples at incubation condition.
A: Pure LPS concentration, CLPS = 0.25 mg/ml;
B: BSA and LPS mixture at concentration ratio, CBSA/CLPS =1;
C: BSA and LPS mixture at concentration ratio, CBSA/CLPS =2;
D: Pure BSA concentration, CBSA = 0.25 mg/ml;
E: Pure BSA concentration, CBSA= 0.5 mg/ml.
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Figure 4.9 Chromatograms of BSA and LPS mixture samples, pure BSA samples at
incubation condition.
A: BSA and LPS mixture at concentration ratio, C BSA/C LPS =4;
B: BSA and LPS mixture at concentration ratio, CBSA/C LPS =8;
C: BSA and LPS mixture at concentration ratio, C BsA/C LPS =16;
D: Pure BSA concentration, C BSA =1 mg/ml;
E: Pure BSA concentration, C BSA = 2 mg/ml;
F: Pure BSA concentration, C BSA = 4 mg/ml.
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Figure 4.10 Chromatograms of BSA and LPS mixture samples, pure LPS sample and
pure BSA samples at without incubation condition.
A: Pure LPS concentration, CLPS = 0.25 mg/ml;
B: BSA and LPS mixture at concentration ratio, C BSA/C LPS =1;
C: BSA and LPS mixture at concentration ratio, C BSA/C LPS =2;
D: Pure BSA concentration, C BSA = 0.25 mg/ml;
E: Pure BSA concentration, C BSA= 0.5 mg/ml.
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Figure 4.11 Chromatograms of BSA and LPS mixture samples, pure BSA samples at
without incubation condition.
A: BSA and LPS mixture at concentration ratio, C BSA/C LPS =4;
B: BSA and LPS mixture at concentration ratio, C BSA/C LPS =8;
C: BSA and LPS mixture at concentration ratio, C BSA/CLPS =16;
D: Pure BSA concentration, C BSA = 1 mg/m1;
E: Pure BSA concentration, CBSA = 2 mg/ml;
F: Pure BSA concentration, C BSA = 4 mg/ml.
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Figure 4.12 Sum of peak areas at specific elution periods for samples prepared with
incubation. A peak area sum was calculated by summing up the total peak areas of
corresponding peak groups in both pure LPS and pure BSA chromatograms. A: peak
group 1, PG1, corresponding to elution period, T r = 6.0 — 7.7 min. B: peak group 2, PG2,
corresponding to elution period, T, = 8.3 — 8.8 min. C: peak group 3, PG3, corresponding
to elution period T r = 9.3 — 9.7 min.
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Figure 4.13 Peak areas at specific elution periods for BSA-LPS mixtures prepared with
incubation. A: peak group 1, PG 1, corresponding to elution period, T r = 6.0-7.7 min. B:
peak group 2, PG2, corresponding to elution period, T r = 8.3-8.8 min. C: peak group 3,
PG3, corresponding to elution period, T r — 9.3-9.7 min. D: peak group 4, PG4,
corresponding to elution period, T r =10.5 — 12.9 min.
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BSA concentration (mg/ml)

Figure 4.14 Peak area comparison of PG1 with incubation.
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Figure 4.15 Peak area comparison of PG2 with incubation.
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Figure 4.16 Peak area comparison of PG3 with incubation.
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Figure 4.17 Peak area comparison of PG4 with incubation.
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Figure 4.18 A S of PG1, PG2, PG3 and PG4 with incubation.

S= Peak area of BSA and LPS mixture — Corresponding sum peak area of pure BSA
and pure LPS
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Figure 4.19 Sum of peak areas at specific elution periods for samples prepared without

incubation. A peak area sum was calculated by summing up the total peak areas of
corresponding peak groups in both pure LPS and pure BSA chromatograms. A: peak
group 1, PG1, corresponding to elution period, T r = 6.0 — 7.7 min. B: peak group 2, PG2,
corresponding to elution period, T r 8.3 — 8.8 min. C: peak group 3, PG3, corresponding
to elution period Tr = 9.3 — 9.7 min.

82

Figure 4.20 Peak areas at specific elution periods for BSA-LPS mixtures prepared

without incubation. A: peak group 1, PG1, corresponding to elution period, T r = 6.0-7.7
min. B: peak group 2, PG2, corresponding to elution period, T r — 8.3-8.8 min. C: peak
group 3, PG3, corresponding to elution period, Tr 9.3-9.7 min.
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Figure 4.21 Peak area comparison of PG1 without incubation.
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Figure 4.22 Peak area comparison of PG2without incubation.
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Figure 4.23 Peak area comparison of PG3 without incubation.
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Figure 4.24 A S of PG1, PG2 and PG3 without incubation.
A S= Peak area of BSA and LPS mixture — Corresponding sum peak area of pure BSA
and pure LPS
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Figure 4.25 Peak area comparison of PG1 with incubation and without incubation.
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Figure 4.26 Peak area comparison of PG2 with incubation and without incubation.
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Figure 4.27 Peak area comparison of PG3 with incubation and without incubation.
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Figure 4.28 Peak area comparison of PG4 with incubation and without incubation.
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Figure 4.29 Peak area percentage comparison of PG1 with incubation and without

incubation.

CHAPTER 5

USE OF CA +2 TO RE-AGGREGATE LIPOPOLYSACCHARIDE (LPS) IN
HEMOGLOBIN SOLUTIONS AND THE SUBSEQUENT REMOVAL OF
ENDOTOXIN BY ULTRAFILTRATION

5.1 Objective
It is known that LPS subunits (monomers) have a molecular weight of approximately
10,000 to 20,000 daltons (Evans-Strickfaden and Oshima, 1996). Normally, these
subunits aggregate into vesicles with a molecular weight around 1,000,000 daltons
(Pearson, 1985b). The aggregation is believed to be facilitated by cations. Because LPS
has negatively charged phosphate groups, cations, especially divalent cations such as Ca +2
and Mg +2 can act as "bridges" between LPS subunits (Schindler and Osborn, 1979),
resulting in LPS bilayer sheets or vesicles with a diameter of the order of 0.1 }gym in water
(Nelsen, 1978; Pearson, 1985b). It is also known that some proteins can disaggregate
endotoxins and form complexes with LPS in biological solutions, which makes the
removal of endotoxin from protein-based biopharmaceutical products more complicated.
In Chapter 3, the concentration effect of hemoglobin on protein-LPS binding and
endotoxin removal was studied.
Some studies have shown that the addition of divalent cations enhanced the LPS
aggregation in water (Galanos and Lüderitz, 1975). However, whether the LPS subunits
bound to protein molecules in a biological solution will re-aggregate upon adding
divalent cations is unknown. In this study, a method of two-stage ultrafiltration was used
to investigate the effect of Ca +2 on LPS re-aggregation in hemoglobin solutions and the
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removal of endotoxin. Pure endotoxin in aqueous solutions can not pass through the
ultrafiltration membranes rated at 300,000 nominal molecular weight cut-off (NMWCO).
If endotoxin aggregates are broken down by protein molecules and form smaller proteinLPS complexes, the complexes will pass the membrane and endotoxin will be found in
the filtrate. If LPS subunits in complexes are re-aggregated and form large vesicles again
in the solution, then the large vesicles will not pass the membrane and endotoxin will not
be found in the filtrate.

5.2 Materials and Methods
5.2.1 Materials
Endotoxin from Escherichia coli 026:B6 and human hemoglobin A o (HbAo , ferrous) were
from Sigma. Hemoglobin and endotoxin solutions were prepared with endotoxin-free
0.15 M NaCl solution. 0.1 M endotoxin-free HC1, 0.1 M endotoxin-free NaOH, NaCl
(molecular biology reagent), CaCl 2 2H 2 0 (molecular biology reagent), endotoxin-free
water and endotoxin detection kit E-TOXATE were from Sigma. Ultrafree-CL
polysulfone 300,000 NMWCO ultrafiltration membrane filters were from Millipore. All
glassware used was sterilized in an autoclave (Series 300, Harvard/LTE) for 1 hr and
followed by heating in an oven (Thelco Model 16, Precision Scientific Co.) at 175 ° C for
3 hrs. All solution transfers were performed by endotoxin-free devices.

5.2.2 Endotoxin Detection
Endotoxin was detected using Limulus amebocyte lysate (LAL) test. Gelation was taken
as the endpoint. Endotoxin from Escherichia coli 055:B5 was used as the standard. For
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standard endotoxin detection, when endotoxin concentration was greater than 0.06
Endotoxin Unit (EU) /ml, solid gel formed and the LAL test gave positive result.

5.2.3 Protein-LPS Binding Study
Seven 0.9 ml hemoglobin A o solutions at various concentrations (Table 5.1) were put into
1.5 ml sterile Eppendorf microcentrifuge tubes respectively, then 0.1 ml 50.0 µg LPS /ml
endotoxin solution was added to each tube. The mixtures were incubated in a water bath
at 37 ° C for 30 minutes. After incubation, the solutions were applied to 300,000
NMWCO polysulfone ultrafiltration membranes and ultrafiltration was performed by
centrifuging at 1800 g for 5 minutes. This is the first ultrafiltration, as shown in Figure
5.1. 0.1 ml filtrate of each solution was set aside for LAL test, and the remaining filtrate
was divided into two parts, one part was used for LPS re-aggregation study with CaC1 2 .
Another was used for a control experiment with NaCI.

5.2.4 Endotoxin Re-Aggregation Study
Seven 0.2 ml filtrates at various hemoglobin concentrations from the first ultrafiltration
were put into 1.5 ml sterile Eppendorf microcentrifuge tubes. Then 0.2 ml of 0.09 M
endotoxin-free CaC1 2 solution was added to each tube. The ionic strength of the CaC12
solution was 0.27 M. The mixtures were incubated in a water bath at 37 ° C for 30
minutes. After incubation, the solutions were applied to 300,000 NMWCO polysulfone
ultrafiltration membranes and the ultrafiltration was performed by centrifuging at 1800 g
for 5 minutes. This is the second ultrafiltration as shown in Figure 5.1. 0.1 ml filtrate of
each solution was subjected to LAL test. In order to conduct a control experiment that
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was used as a comparison to the endotoxin re-aggregation study in CaCl 2 solution, 027
M NaCl solution was used to study the aggregation state of LPS in the mixtures. The
ionic strength of NaCl solution was 0.27 M, as same as that of CaCl 2 solution. The
experiment procedure was similar to that of the endotoxin re-aggregation study in CaC1 2
solution.

5.3 Results and Discussion
5.3.1 Protein-LPS Binding Study
The LAL test results of protein-LPS binding study are shown in Table 5.1. In this study,
the hemoglobin A o concentration in the mixture was changed from 144.0 µg/m1 to 76.5
µg/ml, while the endotoxin concentration was kept the same at 5.0 µg LPS /ml in every
mixture. Meanwhile the HbA o and LPS concentration ratio was changed from 28.8 to
15.3. After the first ultrafiltration, the filtrates of all mixtures formed solid gels in the
presence of LAL lysate, and the LAL test gave positive results. This study shows that
hemoglobin can break endotoxin aggregates and form HbAo- LPS complexes, which is
consistent with the phenomenon reported in Chapter 3.

53.2 Endotoxin Re-Aggregation Study
Table 5.2 shows the LAL test results of the filtrates from the second ultrafiltration. When
the [HbA o ]/ [LPS] was equal to or greater than 17.3, and the corresponding
[Ca+2 ]/[HbA0 ]/[LPS] was equal to or less than 8.3, the mixtures of the LAL lysate and the
filtrate formed solid gels and the LAL tests of the filtrates with Ca+2 gave positive results,
which indicated that endotoxin was found in the filtrates. When the [HbA o]/[LPS] was
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equal to or less than 17.0, and the corresponding [Ca + 2 ]/[HbA o ]/[LPS] was equal to or
greater than 8.5, the mixtures did not form solid gel and the LAL tests of the filtrates with
Ca +2 gave negative results. This indicated no endotoxin was found in those filtrates. In
comparison, for the control experiments with NaCI at the same [HbA o ]/[LPS] and
[Ca+2 1/[HbAo ]/[LPS] ratios, the mixtures of the LAL lysate and the filtrate all formed
solid gels and the LAL tests of the filtrates all gave positive results. This indicated that
endotoxin was found in the filtrates. By comparing the LAL test results of the filtrates
with Ca+2 to the LAL test results of the filtrates with Nat , we can see clearly the effect of
Ca +2 on the re-aggregation of LPS subunits.
The physical meanings of above results may be explained as follows. Pure
endotoxin is usually in aggregate state with a molecular weight around 1,000,000 daltons
and is retained by a 300,000 NMWCO membrane. In this study, HbA o and endotoxin
mixtures at seven different concentration ratios were incubated before the first
ultrafiltration. Hemoglobin molecules broke the endotoxin aggregates and formed
protein-LPS complexes with LPS subunits. As we reported in our previous study (Li and
Luo, 1997), protein concentration has a significant effect on protein-LPS binding and the
amount of endotoxin disaggregated. In other words, the following equilibrium moved
towards the RIGHT-HAND direction as the protein concentration was increased.

However, when Ca +2 was added to all samples after the first ultrafiltration, the cation
began to move the above equilibrium towards the LEFT-HAND direction due to the
"bridging effect", which results in the re-aggregation of LPS subunits. When the
[HbAo ]/[LPS] was decreased from 17.3 to 17.0 or the [Ca+2 ]/[HbAo]/[LPS] was increased
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from 8.3 to 8.5 (Table 5.2), most LPS subunits re-aggregated into large endotoxin
vesicles and were retained by a 300,000 NMWCO membrane, thus no detectable amount
of endotoxin was found in the filtrate of the second ultrafiltration.

5.4 Conclusions
The results of this study have shown that Ca +2 can affect the state of LPS aggregation not
only in water, but also in protein solutions where the protein-LPS complexes exist. The
addition of Ca+2 to protein-LPS mixture can result in the re-aggregation of LPS subunits,
which makes it easier to remove endotoxin from protein solutions via ultrafiltration. This
knowledge is also very useful to design and improvement of chromatographic endotoxin
removal processes.
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Table 5.1 LAL test results of HbA o -LPS binding study.

LAL: Limulus Amebocyte Lysate.
HbAO : hemoglobin A 3 .
LPS: lipopolysaccharide.
a: [HbAo]/[LPS], the concentration ratio of HbA o and LPS.
b: "+", formation of a gel which does not collapse after one 180 0 inversion.
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Table 5.2 LAL test results of endotoxin re-aggregate.
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Figure 5.1. Schematic diagram of experimental procedure: protein/ LPS mixtures at
various concentration ratios were incubated at 37 ° C for 30 minutes. After incubation, the
mixtures were applied to the first ultrafiltration. To each filtrate at various protein/LPS
ratios from the first ultrafiltration Ca +2 or Na+ solution was added respectively. The
resulting mixtures were incubated and the second ultrafiltration was conducted. Gelation
LAL test was used.

CHAPTER 6

QUANTITATIVE DETERMINATION OF CA +2 EFFECTS ON ENDOTOXIN
REMOVAL AND PROTEIN YIELD IN A TWO-STAGE ULTRAFILTRATION
PROCESS

6.1 Objective
It is known that some proteins can bind endotoxins and form protein-LPS complexes in
biological solutions (Zielger et al., 1982; Ziegler et al., 1991; Schumann et al., 1990;
Wakitu et al., 1996; Schlichting et al., 1996). It was reported that hemoglobin not only
can bind but also disaggregate LPS, and enhance LPS activation of Limulus amebocyte
lysate (LAL) in a concentration dependent manner (Kaca et al., 1994; Roth et al., 1994).
In Chapter 3, the concentration effects of hemoglobin and albumin on protein-LPS
binding and endotoxin removal was studied. It was found that the proteins interacted with
LPS and formed protein-LPS complexes, resulting in the disaggregation of LPS vesicles.
Endotoxin subunits have molecular weights of 10,000 or less, depending on the
composition of the solution in which they are present (Gerba and Goyal, 1981).
Aggregated forms of endotoxin range from 300,000 to 1,000,000 daltons (Brown and
Fuller, 1993; Abramson et al., 1981; Sweadner et al, 1977; Hannecart-Pokorni et al.,
1973). The aggregation is believed to be facilitated by cations. Because LPS has
negatively charged phosphate groups, cations, especially divalent cations such as Ca +2 and
Mg+2 can act as "bridges" between LPS subunits (Schindler and Osborn, 1979), resulting
in LPS bilayer sheets or vesicles with a diameter of the order of 0.1 µm in water (Nelsen,

1978; Pearson, 1985). In a previous study, researchers in our research group investigated
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the cation effects on endotoxin removal efficiency and protein recovery in an affinity
chromatographic process (Kang and Luo, 1998). In Chapter 5, studies were performed on
the effects of Ca +2 on LPS re-aggregation in hemoglobin solutions and the removal of
endotoxin. When LPS subunits in complexes were re-aggregated and formed large
vesicles again in the solution, they did not pass through the membrane and endotoxin was
not found in the filtrate.
In the work presented in this article, the method of two stage ultrafiltration was
also used to study the effect of Ca +2 on LPS re-aggregation. Since the chromogenic LAL
assay was employed to detect endotoxin, it was possible to determine endotoxin
concentration quantitatively. The endotoxin removal efficiency after re-aggregation in the
presence of Ca+2 was studied. The yield of hemoglobin was also investigated.

6.2 Experiment
6.2.1 Materials and Methods
Glassware. All glassware used was autoclaved in an autoclave (Series 300, Harvard!LTE)
for 1 hour and followed with heating in an oven (Thelco Model 16, Precision Scientific
Co.) at 175 ° C for 3 hours. All solution transfers were performed by endotoxin-free
devices. Sterile, disposable plasticware was used to prevent endotoxin contamination.
Reagents. Endotoxin-free water from BioWhittaker (BioWhittaker Inc.,
Walkersville, MD) was used for endotoxin dilution and all solution preparations.
Endotoxin from Escherichia coil 026:B6, human hemoglobin A o (HbA o, ferrous), 0.1 M
endotoxin-free HCl, 0.1 M endotoxin-free NaOH, NaC1 (molecular biology reagent),
CaC12•2O(molecuHarbigynt)wefromSiga(Checlo.,St
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Louis, MO). Hemoglobin and endotoxin solutions were prepared with endotoxin-free
0.15 M NaCl solution. Ultrafree-CL polysulfone 300,000 NMWCO (Nominal Molecular
Weight Cut-off) ultrafiltration membrane filters were from Millipore (Millipore
Corporation, Bedford, MA).

6.2.2 Endotoxin Assay
To determine endotoxin concentration, a chromogenic Limulus Amebocyte Lysate (LAL)
test kit QCL-1000 from Bio Whittaker (BioWhittaker Inc., Walkersville, MD) was used.
The chromogenic substrate is a short synthetic polypeptide with an amino acid sequence
that mimics a natural cleavage site in a clotting protein present in the lysate. The
chromogenic p-nitro aniline (pNA) moiety is attached to the end of the peptide as Ac-IleGlu-Ala-Arg-pNA. In the chromogenic LAL test the proenzyme which exists in the

Limulus amebocyte lysate (LAL) was activated by the endotoxin in a water bath at 37 ° C
for 10 minutes. Chromogenic substrate was then added, and the active enzyme caused the
release of pNA from the substrate, producing a yellow color. After 20 minutes, the
reaction was stopped with 25% acetic acid. The intensity of the color change produced by
the substrate cleavage was measured with the UV/VIS spectrophotometer (Hitachi U2000, Hitachi Instruments Inc., Danbury, CT) at 405 nm (Figure 6.3). The results were
compared to a calibration curve to obtain endotoxin concentration. However HbA o also
has a strong absorbance at 405 nm, and it should not be counted in the endotoxin
absorbance. The correction was made by deducting the HbA o absorbance from the total
absorbance of the reaction mixture (Figure 6.2a, Figure 6.2b).
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Endotoxin removal efficiency, ERE, of the ultrafiltration was determined by the
following equation:

of the ultrafiltration (EU/ml).

6.2.3 Protein Assay
The concentration of HbAo

in the solution was measured at 410 run by a UV/VIS

spectrophotometer (Hitachi U-2000, Hitachi Instruments Inc., Danbury, CT). Protein
yield , Y, of the ultrafiltration was determined by the following equation:

concentration in the solution loaded on the ultrafiltration membrane filter (µg/ml).
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6.2.4 The First Stage Ultrafiltration
3.6 m1 HbA 0 solutions at various concentrations (Table 6.1) was incubated with 0.4 ml
50.00 EU/ml endotoxin solution at 37 ° C water bath for 30 minutes, the concentration
ratio of HbA o to endotoxin were 0.90, 1.80, 2.70, 3.60 µg/EU respectively. Sterile,
endotoxin-free culture tubes were used for the incubation. After incubation, the mixture
solutions were placed on 300,000 NMWCO polysulfone ultrafiltration membrane filters
and ultrafiltration was performed by centrifuging the mixture samples at 1800 g for 5
minutes. This is the first stage ultrafiltration, as shown in Figure 6.1. 0.1 ml filtrate of
each solution was set aside for LAL test, and the remaining filtrate was divided into two
parts, one part was used for the second stage ultrafiltration to investigate Ca +2 effect on
endotoxin removal and protein purification with CaC1 2 . Another was used for a control
experiment with NaCl.

6.2.5 The Second Stage Ultrafiltration
Four 1 ml filtrates at various hemoglobin concentrations from the first stage ultrafiltration
were put into sterile endotoxin-free culture tubes. Then 1 ml 0.05 M endotoxin-free CaC12
solution was added to each tube. The ionic strength of the CaC12 solution was 0.15 M.
The mixtures were incubated in a water bath at 37 ° C for 30 minutes. After incubation,
the solutions were applied to 300,000 NMWCO polysulfone ultrafiltration membranes
and the ultrafiltration was performed by centrifuging at 1800 g for 5 minutes. This is the
second stage ultrafiltration as shown in Figure 6.1. 0.1 ml filtrate of each solution was
subjected to LAL test. In order to conduct a control experiment that was used as a
comparison to the endotoxin re-aggregation study in CaCl 2 solution, 0.15 M NaCl
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solution was used to study the aggregation state of LPS in the mixtures. The ionic
strength of NaCl solution was 0.15 M, as same as that of CaC1 2 solution. The experiment
procedure was similar to that of the study with CaC12 solution.

6.3 Results and Discussion
6.3.1 Endotoxin Removal of the First Stage Ultrafiltration
The endotoxin removal efficiency of the first stage ultrafiltration is shown in Table 6.2.
As the HbA o/LPS concentration ratio increased from 0.90 to 3.60 µg/EU, the endotoxin
removal efficiency, ERE, decreased from 98.84% to 88.36%. This phenomena can be
explained as follows: pure endotoxin in water can not pass through the ultrafiltration
membranes rated at 300,000 nominal molecular weight cut-off (NMWCO). When
endotoxin aggregates were broken down by protein molecules and smaller protein-LPS
complexes were formed, the complexes passed the membrane and endotoxin was found
in the filtrate. As observed in Chapter 3, the protein capacity of breaking down endotoxin
is protein concentration dependent. Higher the protein concentration, more the endotoxin
being dissociated. Therefore, at high HbA o/LPS concentration ratios, more endotoxin was
broken down to form smaller protein-LPS complexes, which passed through the
membrane. This resulted in less endotoxin retained by the membrane and lower ERE.

6.3.2 Protein Yield of the First Stage Ultrafiltration
The protein yield of the first stage ultrafiltration is shown in Table 6.2. As the HbA o/LPS
concentration ratio increased from 0.90 to 3.60 µg/EU, the protein yield, Y, increased
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from 79.91% to 95.19%. The binding between the HbA O and the membrane may be the
cause of protein loss during the filtration.

6.3.3 Endotoxin Removal of the Second Stage Ultrafiltration - The Effect of Ca+2 on
Endotoxin Removal
Figure 6.4 shows endotoxin concentrations in feeds loaded on the second stage ultrafilters
and endotoxin concentrations in membrane filtrates of the second stage ultrafiltration in
the situations when Ca +2 or Na+ was added. From Figure 6.4 we can see that at various
HbA0/LPS concentration ratios, the endotoxin concentrations in the filtrates with Ca +2
were much lower than those in the control samples (with Na +).Figure65showt
amount of endotoxin removed from the solution during the second stage ultrafiltration.
The amount of endotoxin removed from the solution with Ca +2 were much higher than
those in the solution with Na+o+.nThedftcxi2rCmavslyhown
in Table 6.3, The ERE with Ca+2 was two to three times of the ERE with Nat .

6.14 Protein Yield of the Second Stage Ultrafiltration - The Effect of Ca +2 on
Protein Yield
Figure 6.6 shows HbA O concentrations in feeds loaded on the second stage ultrafilters and
HbAO concentrations in filtrates of the second stage ultrafiltration. From Figure 6.6 we
can see that at various HbA o/LPS concentration ratios, the curves representing HbA0
concentrations with Ca +2 and with Na+ are almost overlapped, which indicates that the
HbAO concentrations in the filtrates with Ca+2 were very close to those in the control
experiments (with Nat).
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Figure 6.7 illustrates the protein loss during the second stage ultrafiltration. The
amount of HbA O lost from the solution with Ca+2 and Na+ are almost the same, which
indicates that the introduction of Ca +2 has almost no effect on protein yield. Table 4
shows that the HbA 0 yields with Ca +2 are very close to the HbA o yields with Na+ at
various HbA o/LPS concentration ratios.
The physical meanings of above results may be explained as follows. Pure
endotoxin is usually in aggregate state with a molecular weight around 1,000,000 daltons
and is retained by a 300,000 NMWCO membrane. In this study HbA 0 and endotoxin
mixtures at four different concentration ratios were incubated before the first
ultrafiltration, hemoglobin molecules broke the endotoxin aggregates and formed protein-

LPS complexes with LPS subunits. As we reported in our previous study (Li and Luo,
1997), protein concentration has a significant effect on protein-LPS binding and the
amount of endotoxin disaggregated. In other words, the following equilibrium moved
towards the RIGHT-HAND direction as the protein concentration was increased.

As a result, ERE decreased from 98.84% to 88.36%. However, when Ca +2 was
added to all samples after the first ultrafiltration, the cation began to move the above
equilibrium towards the LEFT-HAND direction due to the "bridging effect", which
resulted in the re-aggregation of LPS subunits. Therefore less endotoxin was detected in
the filtrates of the second stage ultrafiltration with Ca +2 (Figure 6.4), and more endotoxin
was removed (Figure 6.5) comparing with the control experiment (with Na +).
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6.4 Conclusions
The results of this study have shown that Ca+2 can affect endotoxin aggregate states not
only in water as reported before, but also in protein solutions where protein-endotoxin
complexes exist. The addition of Ca +2 to protein-endotoxin mixture can result in the reaggregation of endotoxin subunits, which makes it easier to remove endotoxin from
protein solutions through ultrafiltration. The effects of Ca +2 on endotoxin removal
efficiency in the second stage ultrafiltration can be clearly seen by comparing the ERE
with Ca+2 to the ERE with Na+ in the control experiment.
The results also show that the protein yield during ultrafiltration with Ca +2 or with
Na +arelmosth.Tindcaesthproiyldwasntcfeih
process of LPS re-aggregation in the presence of Ca +2 . This phenomenon has potential
utility in ultrafiltration processes to increase endotoxin removal efficiency and in the
mean time maintain protein yield.
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Table 6.1 Protein and endotoxin concentrations in feeds loaded to the first stage
ultrafiltration.

Table 6.2 Endotoxin removal efficiency, ERE, and HbAo yield, Y, of the first stage
ultrafiltration.

111

Table 6.3 Effect of Ca+2 on endotoxin removal efficiency, ERE, of the second stage
ultrafiltration.

Table 6.4 Effect of Ca+2 on protein yield, Y, of the second stage ultrafiltration.
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Figure 6.1 Schematic diagram of experimental procedure. The experimental procedure:
protein/ LPS mixtures at various concentration ratios were incubated at 37 ° C for 30
minutes. After incubation, the mixtures were applied to the first ultrafiltration. To each
filtrate at various protein/LPS ratios from the first ultrafiltration Ca +2 or Na +solutinwa
added respectively. The resulting mixtures were incubated and the second ultrafiltration
was conducted. Chromogenic LAL test was used.
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Figure 6.2a Absorption spectrum of 50 µg/ml LPS in 1 cm cuvette.
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Figure 6.2b Absorption spectrum of 225 µg/m1 HbAo in 1 cm cuvette.
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Figure 6.3 Principle of chromogenic Limulus amebocyte lysate (LAL) test.
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Figure 6.4 Endotoxin concentration in the second stage ultrafiltration.
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Figure 6.5 Endotoxin removed during the second stage ultrafiltration.
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Figure 6. 6 Protein concentration in the second stage ultrafiltration.
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Figure 6.7 Protein loss during the second stage ultrafiltration.

CHAPTER 7

7.1 Conclusions
From this study the following conclusions can be made 1) some proteins have interaction
with endotoxin while others do not. 2) Protein concentration has effect on protein-LPS
binding and endotoxin removal. 3) When LPS is dissociated by BSA, large aggregates
are disaggregated to form smaller size fragments. 4) Not only can Ca+2 act as "bridges"
between LPS subunits in aqueous solution, it can also re-aggregate LPS in protein
solution where LPS is disaggregated by protein. Such disaggregation improves endotoxin
removal and does not lose protein recovery.
From the study of Endotoxin Disaggregation by Protein and Protein

Concentration Effect on Protein-LPS Binding and Endotoxin Removal, we can see that
chicken egg white lysozyme and bovine heart cytochrome C did not disaggregate
endotoxin, that is, these two proteins did not break endotoxin into small fragments.
Hemoglobin and albumin could break endotoxin aggregates. Also concentration of these
two proteins had a significant effect on the amount of endotoxin disaggregated and the
amount of protein-LPS complex formed. Ultimately, protein concentration affected the
rate of endotoxin removal by ultrafiltration membrane processes.
In the study of Size Exclusion High Performance Liquid Chromatography (SE-

HPLC) Studies on Endotoxin Dissociation by Bovin Serum Albumin (BSA), BSA size
exclusion high performance liquid chromatography (SE-HPLC) was used to investigate
LPS disaggregation by BSA. Under the study experiment condition, which pre-treated
BSA and LPS mixtures with incubation at 37 ° C for 30 minutes, BSA to LPS
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concentration ratio (C BSA/C LPS) was 16. First, it was found that LPS was disaggregated by
BSA. After disaggregation, the major LPS peak, peak group 1, retention time T r = 6.0 —
7.7, was disaggregated and peak area reduced to 17.2% comparing with nondisaggregated LPS peak area.
Second, BSA concentration in the BSA and LPS mixtures had effect on LPS
disaggregation. As BSA concentration increased in the BSA and LPS mixtures, more
major peak of LPS, peak group 1, which retention time T r= 6.0 — 7.7, was disaggregated,
and more smaller size fragments were formed. Under the study experiment condition,
which pre-treated BSA and LPS mixtures with incubation at 37 ° C for 30 minutes. When
BSA to LPS concentration ratios (C BSA/)LwerCPat1,S2486inBAdLPS
mixture solutions, the major peak area of LPS, peak group 1, which retention time T r =
6.0 — 7.7, peak area reduced to 72.3%, 42.1%, 18.4%, 15.2% and 17.2 % respectively
comparing with the non-disaggregated LPS peak area.
Third, pre-incubation of BSA and LPS mixture solutions had effect on LPS
disaggregation. Under pre-incubation condition, much more LPS was disaggregated by
BSA comparing with at non pre-incubation condition. When BSA to LPS concentration
ratio (CBSA/)LwerCPat1,S248nd6pre-icubatond,pekgru1
which retention time T r = 6.0 — 7.7, peak area reduced to 72.3%, 42.1%, 18.4%, 15.2%
and 17.2% comparing with non-disaggregated LPS peak. With same BSA to LPS
concentration ratio, at non pre-incubation condition, peak group 1 area only reduced to
98.1%, 72.9%, 65.2%, 57.7% and 49.0%
In Qualitative Study on Ca +2 Re Aggregate Endotoxin in HbAo Solutions and
Subsequent Removal of Endotoxin by Ultrafiltration, a method of two-stage ultrafiltration
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was used to investigate the effect of Ca+2 on the state of LPS aggregation in HbAo
solutions. Qualitative gelation Limulus amebocyte lysate (LAL) test was used to detect
endotoxin. Some studies have shown that in aqueous solution, divalent cation can act as
"bridges" between LPS subunits, so that LPS form large vesicles. The reason is LPS has
negatively charged phosphate groups, cations, especially divalent cations such as Ca +2
and Mg +2 can act as "bridges" between LPS subunits, resulting in LPS bilayer sheets or
vesicles with a diameter of the order of 0.1µm in water. Such property has potential
utility in endotoxin removal. Through this study, it was found that Ca +2 re-aggregated
LPS subunits into large vesicles in protein solution, hence the re-aggregated LPS was
retained by a 300,000 nominal molecular weight cut-off ultrafiltration membrane,
therefore endotoxin was removed subsequently. Such re-aggregation occurred at

greater than 8.5
In the study of Quantitative Determination of Ca

+2

Effects on Endotoxin Removal

and Protein Yield in A Two-Stage Ultrafiltration, the method of two-stage ultrafiltration
was also used to study the effect of Ca+2 on LPS re-aggregation. By using of
chromogenic LAL assay, it is possible to get LPS removal efficiency. It was found that,
at various protein to endotoxin concentration ratios, after the LPS re-aggregation by Ca +2 ,
endotoxin removal efficiency was in the range of 54.78 to 73.10%, meanwhile protein
yield was in the range of 71.57 to 89.54%.
Those results are significant for endotoxin removal process design. For endotoxin
removal design, not only should solution composition be considered, but also
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concentration of each component should be taken into account. Especially for membrane
process or chromatography process taking advantage of endotoxin molecular size, from
this study it is clear that at different concentration composition, endotoxin aggregate size
will vary, such endotoxin size change will affect endotoxin removal remarkably.

7.2 Recommendations
Further studies are recommended: First, to investigate size and molecular weight of LPS
aggregates and protein-LPS mixture. Since no proper LPS molecular size standards were
available, the size of LPS aggregate was not studied. The experiments can be carried out
by using Minidawn Laser Scattering Device (Wyatt Technology Corporation, Santa
Barbara, CA). Second, to investigate incubation temperature effects on LPS
disaggregation by protein. Third, to investigate incubation time effects on LPS
disaggregation by protein.
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